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Hospital equipment and surfaces can harbour Klebsiella pneumoniae. In the absence of 
effective cleaning, anyone who encounters these surfaces can unknowingly spread this 
opportunistic pathogen throughout the hospital. This study aimed to investigate the prevalence 
of K. pneumoniae on inanimate surfaces and evaluate the genetic diversity, antibiotic resistance 
and virulence profile of the recovered isolates. Overall, 777 swab samples were collected from 
four different South African public hospitals classified as central (A), tertiary (B), regional (C) 
and district (D). These samples were taken from 11 predetermined surfaces present in three 
different wards: the intensive care unit (ICU), paediatric and general. K. pneumoniae was 
identified using polymerase chain reaction (PCR) followed by antibiotic susceptibility testing 
using disk diffusion. Extended-spectrum β-lactamases (ESBL) producers were characterised 
using the combination disc method. Six resistance and three virulence genes were screened 
using PCR. The genetic diversity of the isolates was examined using enterobacterial repetitive 
intergenic consensus (ERIC)-PCR. Collectively, 75 (10%) K. pneumoniae isolates were 
recovered from the collected samples. The isolates recovered were equally abundant in tertiary 
hospital B and district hospital D. The recovery of K. pneumoniae was highest in the paediatric 
ward. Six sites harboured K. pneumoniae wherein the occupied beds were the most heavily 
contaminated. Thirty (40%) isolates were identified as ESBL producers and detected in high 
quantities in tertiary hospital B and the ICU. The ESBLs were mostly classified as multidrug-
resistant (MDR), displaying higher resistance levels to the antibiotics screened than non-
ESBLs. Majority of the ESBLs harboured the blaCTX-M group one resistance gene, which was 
significantly (p<0.05) associated with the aminoglycoside [aac(3')-II and aac(6')-Ib] and 
fluoroquinolone genes (qnrB) screened. The prevalence of virulence genes was high, mrkD 
(95%), wabG (93%) and entB (92%). ERIC-PCR demonstrated that clonally related isolates 
were recovered from different sites within the same hospital suggesting bacterial transmission. 
This study demonstrated that K. pneumoniae could contaminate diverse surfaces, and the 
persistence allowed for dissemination within the public hospital environment. The study's 
findings highlighted the importance of regularly monitoring hospital surfaces and emphasised 
on the need to strengthen current infection prevention and control (IPC) measures in hospitals 





INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Background information 
The terms 'hospital-acquired infections' (HAIs) and 'nosocomial infections' can be used 
interchangeably to describe infections that arise in patients 48 hours or more after being 
admitted into a healthcare facility or within 30 days after being discharged (Revelas, 2012). 
These infections are non-existent when a patient is first admitted. Thus, they result from 
exposure to infectious agents within the healthcare facility (Ali et al., 2018; Revelas, 2012). 
The leading infectious agents are bacteria; however, viruses and fungal parasites can also be a 
likely cause (Khan et al., 2017). Six bacterial species commonly cause HAIs. These six species 
are collectively known as the ESKAPE pathogens, and it includes Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa and Enterobacter species (Santajit & Indrawattana, 2016).  
Antibiotics are essential in treating and preventing infections. However, a rise in antibiotic-
resistant bacteria has been observed due to selective pressures from the misuse and overuse of 
antibiotics (Zhen et al., 2019). ESKAPE pathogens, in particular, are notoriously known for 
'escaping' the action of antibiotics, thus posing as a risk (Zhen et al., 2019). This increased 
resistance has reduced the number of effective antibiotics; hence the World Health 
Organization (WHO) has declared that specific pathogens require new antibiotics. Based on 
importance, these pathogens are grouped into three categories: critical, high and medium 
priority (Mulani et al., 2019). Gram-negative bacteria such as extended-spectrum β-lactamase 
(ESBL) resistant K. pneumoniae and Enterobacter species along with carbapenem-resistant K. 
pneumoniae, Enterobacter species, A. baumannii and P. aeruginosa, are listed under critical 
(Mulani et al., 2019). Whereas, Gram-positive bacteria, namely methicillin-resistant S. aureus 
(MRSA) and vancomycin-resistant E. faecium (VRE) and S. aureus (VRSA), are classified as 
high priority (Mulani et al., 2019). This suggests that the four Gram-negative ESKAPE 
pathogens are a greater concern since some bacterial strains are resistant to all or nearly all 
antibiotics (Wyres & Holt, 2018). Nonetheless, the detrimental effects associated with HAIs 
include a prolonged hospital stay, higher healthcare costs and an increase in morbidity and 




Bacteria can be transmitted to patients in various ways. Firstly, through the hands of healthcare 
workers who may have encountered an infected patient during daily care. These contaminated 
hands can contact another patient, thus facilitating bacterial transmission (Facciolà et al., 
2019). Secondly, a patient can shed microorganisms onto surrounding surfaces where they can 
persist. When healthcare workers touch these surfaces, their hands become contaminated with 
bacteria which may spread to other patients (Facciolà et al., 2019; Suleyman et al., 2018). 
Lastly, direct transmission of bacteria can occur when a patient encounters a contaminated 
surface (Suleyman et al., 2018). 
Maryam et al. (2014) detected Klebsiella on in-vitro fertilisation (IVF) stands and stethoscopes 
in a Nigerian teaching hospital. Likewise, Ayatollahi et al. (2017) reported the recovery of 
Klebsiella from 17 different medical and non-medical surfaces in Iran. Examples of 
contaminated surfaces included laryngoscopes, ventilators, telephones, handsets, surgical 
instruments, patients' beds and oxygen masks. Given this information, it is essential to regularly 
monitor hospital surfaces to detect pathogens (Galvin et al., 2012). Such data can help 
recognise which surfaces are easily contaminated with bacteria, thus assisting with infection 
prevention and control (IPC) measures in place (Otter et al., 2011).  
 
1.2 Taxonomy and classification of Klebsiella 
The Klebsiella genus was named in 1885 as a tribute to the late Edwin Klebs, who was a 
German microbiologist (Martínez et al., 2004). Klebsiella is classified under the 
Enterobacteriaceae family that consists of other Gram-negative bacteria such as Escherichia 
coli, Yersinia, Shigella and Salmonella species (Barrios-Camacho et al., 2019; Martin & 
Bachman, 2018). Klebsiella species have been detected in various niches such as water, soil, 
plants, animals and humans (Merla et al., 2019).  
K. pneumoniae is the dominant species in this genus; thus it is the most common cause of 
infections in humans (Garza-Ramos et al., 2018; Merla et al., 2019). Within this species, 
several different phylogroups exist. Each phylogroup consists of distinct species that are 
closely related (Barrios-Camacho et al., 2019; Garza-Ramos et al., 2018; Passet & Brisse, 
2018). The first phylogroup (KpI) is the most common and designated as K. pneumoniae, which 
has three subspecies, namely K. pneumoniae subsp. pneumoniae, K. pneumoniae subsp. 
rhinoscleromatis and K. pneumoniae subsp. ozaenae (Brisse et al., 2014; Garza-Ramos et al., 




they cause distinct diseases in humans, namely rhinoscleroma and ozaena, respectively (Fevre 
et al., 2011). The rarely isolated second phylogroup (KpII) is Klebsiella quasipneumoniae. 
This species has two subspecies known as K. quasipneumoniae subsp. quasipneumoniae (KpII-
A) and K. quasipneumoniae subsp. similipneumoniae (KpII-B) (Garza-Ramos et al., 2018; 
Martin & Bachman, 2018). The third phylogroup (KpIII) is Klebsiella variicola (Garza-Ramos 
et al., 2018). KpII and KpIII are also responsible for causing infections in humans. However, 
the latter phylogroup has also been detected in various environmental sources (Holt et al., 2015; 
Martin & Bachman, 2018).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
Klebsiella oxytoca is the second most frequently encountered species within this genus that 
causes human infections (Merla et al., 2019). This species also consists of several closely 
related but distinct species that form different phylogroups. K. oxytoca, Klebsiella 
michiganensis and Klebseilla grimontii belong to phylogroup two (KoII), one (KoI) and six 
(KoVI), respectively (Merla et al., 2019). Based on rpoB gene sequences, other species such 
as Klebsiella planticola, Klebsiella ornithinolytica and Klebsiella terrigena, have been 
reclassified and now belong to the genus Raoultella (Martínez et al., 2004).  
 
1.3 Genome composition of Klebsiella   
The K. pneumoniae genome consists of approximately 5000-6000 genes. Around 2000 of those 
genes form part of the core genome; thus, they are usually conserved and present in more than 
95% of isolates (Martin & Bachman, 2018). The core genome encodes genes that contribute to 
the survival of K. pneumoniae in different niches. The remaining genes (approximately 3500) 
are a part of the accessory genome that varies between isolates (Wyres & Holt, 2018). Genes 
from the accessory genome can be chromosomally encoded or plasmid-borne. Besides their 
role in specific processes, these genes can also encode different virulence factors and antibiotic-
resistant mechanisms (Martin & Bachman, 2018).   
 
1.4 Characteristics associated with Klebsiella  
Species under the genus Klebsiella are Gram-negative, non-motile, non-spore-forming and 
medium-size (0.4-0.6 x 2-3 µm) rod-shaped bacteria (Aher et al., 2012; Barrios-Camacho et 
al., 2019). These microorganisms are facultative anaerobes that are lactose fermenting, 
catalase-positive and oxidase-negative (Aher et al., 2012; Barrios-Camacho et al., 2019; Martin 




can grow on ordinary laboratory solid media where they form circular, convex, smooth, 
glistening and mucoid colonies (Barrios-Camacho et al., 2019; Martin & Bachman, 2018; 
Ristuccia & Cunha, 1984). The optimal growth conditions are 35 °C to 37 °C and a pH of 7.2 
(Ristuccia & Cunha, 1984).  
 
1.5 The different phenotypic and genotypic methods used to identify Klebsiella  
Conventional phenotypic methods commonly used to identify bacteria include observing 
specific growth patterns on laboratory media, performing Gram staining tests and taking note 
of specific biochemical characteristics (Van Veen et al., 2010). These phenotypic methods are 
labour intensive, time-consuming and utilise excessive laboratory material (Franco-Duarte et 
al., 2019; Van Veen et al., 2010). Furthermore, the outcomes obtained from phenotypic tools 
may be difficult to interpret or inconclusive (Van Veen et al., 2010). This is because phenotypic 
and biochemical characteristics are unstable and very similar amongst certain species within 
the Klebsiella genus (Barrios-Camacho et al., 2019; Fonseca et al., 2017).  
Genotypic methods such as polymerase chain reaction (PCR), real-time (RT)-PCR and whole-
genome sequencing (WGS) have been used to identify bacteria to address some of the 
shortcomings associated with phenotypic methods (Franco-Duarte et al., 2019; Váradi et al., 
2017). Genotypic methods are sensitive, discriminatory and the results can be generated 
quickly. Furthermore, genotypic tools can identify un-culturable bacteria, thus identifying 
more diverse microbial species (Franco-Duarte et al., 2019). 
 
1.5.1 The cultivation of Klebsiella using laboratory media  
MacConkey agar provides ideal conditions for the growth of Klebsiella, where it forms pink 
mucoid bacterial colonies (Aher et al., 2012). Lactose is one of the critical components of this 
agar. Therefore, bacterial species fermenting lactose (e.g. E. coli, Enterobacter species and 
Klebsiella species) will display pink colonies. Whereas species not fermenting lactose (e.g. 
Pseudomonas, Salmonella and Shigella species) will appear as colourless colonies (Elazhary 
et al., 1973; Humphries & Linscott, 2015). MacConkey agar also contains crystal violet and 
bile salt. These two components impede the growth of most Gram-positive bacteria (Bonnet et 




MacConkey-Inositol-Carbenicillin agar is also an alternative growth media used to detect 
Klebsiella (Ohtomo & Saito, 2003). This agar differs from MacConkey agar in that the lactose 
is substituted with inositol, and the media is supplemented with carbenicillin (Gao et al., 2010). 
Most Klebsiella strains are highly resistant to carbenicillin and can ferment inositol, resulting 
in red-pink colonies (Bagley & Seidler, 1978; Gao et al., 2010).  
 
1.5.2 Analytical profile index  
The analytical profile index (API) 20 E system is also used to identify species belonging to the 
Enterobacteriaceae family. This identification method involves a plastic strip with capsules 
containing 20 different dehydrated biochemical substrates that are inoculated with a bacterial 
suspension (Maina et al., 2014; O'Hara, 2005). After an 18 to 24 hour incubation, outcomes 
are analysed, and a seven-digit number is generated to allow species identification using a 
database (O'Hara, 2005; Washington, 1976).  
 
1.5.3 Mass spectrometry  
Klebsiella species can be identified using matrix-assisted laser desorption/ionisation-time of 
flight (MALDI-TOF) mass spectrometry (Barrios-Camacho et al., 2019). For each 
microorganism, this method generates a unique mass spectral fingerprint that will be compared 
to a known mass spectral fingerprint stored on the database (Croxatto et al., 2012; Singhal et 
al., 2015). Although this technique is simple, fast and cost-effective, misidentifications have 
been reported (Barrios-Camacho et al., 2019). Using WGS, Long et al. (2017) discovered that 
isolates previously described as K. pneumoniae using MALDI-TOF, were in fact, K. variicola 
and K. quasipneumoniae (Long et al., 2017). The misidentification probably occurred because 
the database may lack well-characterised data for all the distinct species in the K. pneumoniae 
phylogroup (Barrios-Camacho et al., 2019; Rodrigues et al., 2018).  
 
1.5.4 Polymerase chain reaction-based methods 
PCR was developed in the 1980s and has been used to identify bacteria (Franco-Duarte et al., 
2019). K. oxytoca and K. pneumoniae have been identified with PCR targeting the pehX and 
khe gene, respectively. These genes encode for polygalacturonase and haemolysin, respectively 




K. pneumoniae, K. quasipneumoniae and K. variicola have the blaSHV, blaOKP and blaLEN genes 
encoded on their chromosomes, respectively (Fonseca et al., 2017). These three β-lactamase 
chromosomal genes have resulted in the development of PCR primers that could be utilised for 
identification purposes. These primers target the β-lactamase genes along with the flanking 
chromosomal encoded deoR gene. The latter gene's inclusion avoids detecting any plasmid-
encoded β-lactamase genes (Fonseca et al., 2017).  
 
1.5.5 Sequencing-based methods  
The direct sequencing of specific deoxyribonucleic (DNA) markers is one of the most reliable 
methods to identify microorganisms (Rodrigues et al., 2018). The most popular marker used is 
the 16S ribosomal ribonucleic acid (rRNA) gene; however, other markers such as the rpoB 
gene can also be used (Franco-Duarte et al., 2019). The resulting sequence generated is 
compared to other reference sequences present in private or publicly available databases. This 
gives rise to a similarity percentage which allows the isolate in question to be identified to 
species or genus level (Petti, 2007).   
Alternatively, WGS can also identify bacteria and serve as a molecular typing method (Kwong 
et al., 2015; Váradi et al., 2017). This high-resolution method reveals detailed genetic 
information concerning the virulence and antibiotic resistance determinants linked with 
microorganisms of interest (Aliyu, 2014; Kwong et al., 2015). Despite these advantages, the 
limitations affiliated with WGS include high costs and the data generated is difficult to interpret 
(Aliyu, 2014; Kwong et al., 2015). 
 
1.6 Infections and carriage of Klebsiella 
Bacteria colonise a variety of bodily surfaces without causing infection or disease (Dani, 2014). 
In humans, K. pneumoniae commonly colonise the gastrointestinal tract as well as the 
nasopharynx. It is also a transient member of the skin (Martin & Bachman, 2018). Once this 
bacterium establishes a route of entry from the colonisation sites into tissues, an infection can 
occur (Paczosa & Mecsas, 2016). Infections can either be hospital-acquired or community-
acquired. HAIs such as urinary tract infections (UTIs), pneumonia and bacteremia occur mostly 
in immunocompromised individuals. Such medical conditions can typically be caused by 





Community-acquired infections such as pneumonia, UTIs, pyogenic liver abscess, meningitis 
and endophthalmitis are caused by classical and hypervirulent strains of K. pneumoniae 
(Navon-Venezia et al., 2017; Paczosa & Mecsas, 2016). Hypervirulent strains are concerning 
since they can elicit infections in immunocompromised individuals and those in good health. 
Furthermore, infections caused by these strains occur in unusual sites and can spread to 
multiple other sites (Shon et al., 2013). The most frequent sites of infection include the liver, 
eyes, lungs and central nervous system. However, these strains have also been infrequently 
linked to infections occurring in other sites such as the spleen, kidney and prostate (Choby et 
al., 2020). Hypervirulent strains are seldomly resistant to antibiotics; however, resistance has 
been detected due to the dissemination of mobile genetic elements (MGEs) harbouring 
antibiotic resistance genes (Lee et al., 2017). 
 
1.7 Virulence factors associated with Klebsiella 
For bacteria to cause an infection or disease, it must have different virulence factors expressed 
at different stages (Ramachandran, 2014). These virulence factors allow the bacterium to thrive 
during infection by providing functions such as evasion from the host's immune system and 
allowing bacteria to travel across barriers, which aids in their replication and dissemination 
(Ramachandran, 2014). The four virulence factors in K. pneumoniae (Martin & Bachman, 
2018) are described below.  
 
1.7.1 Capsule 
The capsule is an imperative virulence factor in K. pneumoniae (Huynh et al., 2017). This 
structure is located outside of the bacterial cell and comprises of polysaccharides containing 
various sugars (Schembri et al., 2005; Wilson et al., 2002). The capsule plays an essential role 
in protecting the bacteria from phagocytosis, opsonisation and antibiotics (Struve et al., 2008; 
Wilson et al., 2002).  
The capsule is synthesised by the capsular polysaccharide synthesis (cps) gene cluster found 
on the chromosome (Hsu et al., 2016). The 5′ end region of the gene cluster has six different 
genes: galF, cpsACP, wzi, wza, wzb and wzc (Pan et al., 2015). Wzi is one of the most critical 
genes as it encodes a protein responsible for facilitating the attachment of the capsule to the 
outer membrane (Paczosa & Mecsas, 2016). Furthermore, wzi is often used for capsular typing 




differences in the gene making it more specific and more sensitive compared to previously used 
techniques such as serotyping (Martin & Bachman, 2018; Paczosa & Mecsas, 2016; Pan et al., 
2015). Currently, 79 different capsular types (K antigens) have been described for Klebsiella, 
and the most common include K1, K2, K5, K20, K54 and K57 (Catalan-Najera et al., 2017; 
Hsu et al., 2016). The 3′ end of the cps gene cluster consists of two genes, namely gnd and ugd. 
The gene cluster's middle region is highly variable, and the genes located within encode 
proteins involved in polymerisation. An example is wzy, a gene also used for capsular typing 
(Pan et al., 2015).  
Hypervirulent K. pneumoniae strains overproduce polysaccharides resulting in a larger capsule 
(Lee et al., 2017). The enhanced capsule is activated by chromosomal mutations that occur in 
the rcsA and rcsB genes that encode a signalling system responsible for regulating the synthesis 
of the capsule (Arena et al., 2017; Paczosa & Mecsas, 2016). Transcriptional regulators initiate 
the synthesis of the capsule. These regulators are encoded by the rmpA and rmpA2 genes 
located on chromosomes or plasmids (Arena et al., 2017; Paczosa & Mecsas, 2016). The magA 
gene encodes a polymerase enzyme involved in capsule synthesis. However, this gene is only 
associated with highly pathogenic K1 hypervirulent strains (Catalan-Najera et al., 2017).  
 
1.7.2 Pili (Fimbriae) 
For bacteria to cause an infection, it must be capable of adhering to the host structures (Struve 
et al., 2008). Adherence is achieved through pili defined as small protein filamentous structures 
that protrude from the bacteria's surface (Martin & Bachman, 2018). In K. pneumoniae, type 
one and type three pili are the two most common, and the genes that encode them form part of 
the core genome (Alcántar-Curiel et al., 2013; Martin & Bachman, 2018). Pili is essential in 
biofilm formation on living and non-living surfaces (Paczosa & Mecsas, 2016). 
Type one pili are encoded by the fimABCDEFGHIK gene cluster (Stahlhut et al., 2012). A 
large proportion of the structure is the major subunit known as FimA, encoded by the fimA 
gene. The tip of the pili is the minor subunit known as FimH, encoded by the fimH gene 
(Alcántar-Curiel et al., 2013; Paczosa & Mecsas, 2016). Type one pili are detected in most K. 
pneumoniae isolates and other species in the Enterobacteriaceae family (Paczosa & Mecsas, 
2016). 
Type three pili are encoded by the mrkABCDF gene cluster (Ares et al., 2016). The mrkA gene 




other hand, the minor subunit known as mrkD is encoded by the mrkD gene, which forms the 
tip of the structure (Alcántar-Curiel et al., 2013; Paczosa & Mecsas, 2016). Type three pili are 
expressed in most K. pneumoniae isolates (Paczosa & Mecsas, 2016).  
 
1.7.3 Siderophores 
K. pneumoniae needs iron to grow and thrive during an infection (Paczosa & Mecsas, 2016). 
However, there is often a meagre supply available in the host since it is bound to various other 
proteins such as haemoglobin and transferrin (Podschun & Ullmann, 1998). K. pneumoniae 
can secrete siderophores to acquire bound and unbound iron present in the host environment 
(Paczosa & Mecsas, 2016).  
There are four different types of siderophores (Martin & Bachman, 2018). Enterobactin is 
synthesised by the entABCDEF gene cluster located on the chromosome. The proteins 
responsible for transporting this siderophore are encoded by the fepABCDG gene cluster 
(Paczosa & Mecsas, 2016). As the most common siderophore, enterobactin has the highest iron 
affinity; furthermore, it is present in most classical and hypervirulent strains (Paczosa & 
Mecsas, 2016). Other siderophores encoded by genes belonging to the accessory genome 
include salmochelin, yersiniabactin and aerobactin. These siderophores are predominantly 
found in hypervirulent strains and rarely detected in classical strains (Martin & Bachman, 2018; 
Paczosa & Mecsas, 2016).  
The iucABCD gene cluster is responsible for synthesising aerobactin, whereas the associated 
transport proteins are encoded by the iutA gene (Paczosa & Mecsas, 2016). The synthesis of 
salmochelin is encoded by the iro loci (Russo & Marr, 2019). The synthesis of yersiniabactin 
is encoded by the irp genes, and the transport molecules are encoded by the ybt and fyu genes 
(Paczosa & Mecsas, 2016). This siderophore cannot acquire iron in the presence of transferrin. 
Transferrin is a protein concentrated in blood plasma, as such, infections caused solely by 
yersiniabactin-producing strains will not proliferate to other regions of the body, but they 
remain in the lung resulting in lung infections (Paczosa & Mecsas, 2016).  
 
1.7.4 Lipopolysaccharide 
The lipopolysaccharide is a significant constituent of the outer membrane. This structure is 




(Huynh et al., 2017; Steimle et al., 2016) coded by the genes in the lpx, waa and wb gene 
clusters, respectively (Paczosa & Mecsas, 2016). Nine different O antigens are reported in 
Klebsiella species, and the most common are O1, O2 and O3 (Martin & Bachman, 2018). Lipid 
A is the most toxic and crucial component because the host's innate immune system recognises 
it through toll-like receptor 4 (TLR4). Once the TLR4 is activated, it causes the release of pro-
inflammatory cytokines which induce inflammation (Ramachandran, 2014; Wilson et al., 
2002). When the host's immune cells are overstimulated, septic shock can occur (Shapira et al., 
1996).  
 
1.8 Antibiotic resistance  
The rise in antibiotic resistant bacteria is attributable to the use and misuse of antibiotics in the 
medical and agricultural industries (Von Wintersdorff et al., 2016). A microbe is considered 
resistant when it can grow and survive despite being exposed to an antibiotic at a particular 
concentration that would normally inhibit or kill a microorganism of the same species (Sabtu 
et al., 2015).  
Resistance can occur in several ways. Firstly, bacteria can be naturally resistant to some 
antibiotics. This is known as intrinsic resistance (Blair et al., 2015). Secondly, through 
chromosomal mutatations. Lastly, via the acquisition of resistance genes (Blair et al., 2015; 
Sabtu et al., 2015). Resistance genes are present on different MGEs that can be shared between 
related and unrelated species. This genetic sharing occurs through horizontal gene transfer 
(HGT) or lateral genetic transfer (LGT) defined as the movement of DNA from one cell to 
another (Lerminiaux & Cameron, 2019; Stokes & Gillings, 2011; Sultan et al., 2018). This 
movement occurs via conjugation, transduction or transformation (Von Wintersdorff et al., 
2016). Once movement occurs, the different MGEs are integrated into the genome via 
autonomous replication, transposition, site-specific recombination or homologous 
recombination (Stokes & Gillings, 2011). The different MGEs that exist include plasmids, 
transposons, insertion sequences, integrons, integrative conjugative elements as well as gene 





1.9 The mechanism of action of the different antibiotics and how resistance is expressed  
1.9.1 β-lactams 
The β-lactams have been used in clinical settings since the 1940s (Navon-Venezia et al., 2017). 
Currently, this antibiotic class is the most prescribed worldwide due to its effectiveness in 
treating a variety of infections and being well tolerated by most patients (Bush & Bradford, 
2016; Navon-Venezia et al., 2017). β-lactam antibiotics are classified into four groups: 
penicillins (e.g. ampicillin), cephalosporins (e.g. ceftriaxone), carbapenems (e.g. meropenem) 
and monobactams (e.g. aztreonam) (Bush & Bradford, 2016; Worthington & Melander, 2013). 
Structurally, all β-lactams contain a β-lactam ring and function by inhibiting bacterial cell wall 
synthesis by binding to penicillin-binding proteins (PBPs). This prevents these enzymes from 
executing their role in cross-linking peptidoglycan (a key component of the cell well), leading 
to cell lysis (Bush & Bradford, 2016; Drawz & Bonomo, 2010; Worthington & Melander, 
2013). The expression of β-lactamases is the most imperative resistance mechanism in Gram-
negative bacteria to evade the inhibitory action of β-lactam antibiotics (Cantón et al., 2012; 
Drawz & Bonomo, 2010).  
β-lactamases can enzymatically hydrolyse the β-lactam ring, thereby inactivating the antibiotic 
(Worthington & Melander, 2013). Several different enzymes have been detected over the years 
and grouped according to two various schemes: The Bush-Jacoby-Medeiros functional 
classification and the Amber molecular classification (Shaikh et al., 2015). The former utilises 
four groups (1,2,3,4) to classify the enzymes based on functional properties. In contrast, the 
latter utilises four classes (A, B, C, D), basing the classification on the enzyme's protein 
homology (Drawz & Bonomo, 2010; Shaikh et al., 2015). Enzymes that fall under class A, C 
and D, are regarded as serine β-lactamases. In contrast, enzymes in class B are regarded as 
metallo-β-lactamases (Shaikh et al., 2015). Listed below are the different β-lactamases 
enzymes detected in Klebsiella species. 
 
1.9.1.1 Classical β-lactamases and extended-spectrum β-lactamases  
TEM-1, TEM-2 and SHV-1 classical enzymes were the first class A serine β-lactamases 
detected (Drawz & Bonomo, 2010; Martin & Bachman, 2018; Pitout & Laupland, 2008; Shaikh 
et al., 2015). In K. pneumoniae, the latter enzyme is encoded by a gene located in the core 




2018). The frequent usage of β-lactams has led to the evolution of mutated β-lactamases, 
known as ESBLs (Shaikh et al., 2015).  
ESBL-producing isolates are resistant to third and fourth-generation cephalosporins along with 
monobactams (Cantón et al., 2012). The 1980s and 1990s, the TEM and SHV type ESBLs 
were very popular, and research suggests that they originated from point mutations within 
classical enzymes (Cantón et al., 2012; Zeynudin et al., 2018). Currently, the CTX-M type is 
the most popular and most extensive group of ESBLs (Cantón et al., 2012; Zeynudin et al., 
2018).  
The CTX-M family originated from the chromosome of Kluyvera species; however, several 
studies have identified this family in various other microorganisms, including Klebsiella 
species due to HGT (Shaikh et al., 2015; Zeynudin et al., 2018). The CTX-M family consists 
of more than 170 variants which are classified into five major groups (Zeynudin et al., 2018). 
CTX-M-15 is classified under group one and is the most dominant variant in Africa. 
Furthermore, it has been frequently observed in different environments and hosts (Cantón et 
al., 2012; Zeynudin et al., 2018). Overall, these plasmid-encoded ESBLs are worrisome 
particularly in clinical settings because these strains are often associated with additional 
antibiotic resistance genes, conferring resistance to other clinically important antibiotic classes 
(Martin & Bachman, 2018; Rawat & Nair, 2010).  
A military hospital in Tunisia reported the recovery of 28 ESBL isolates from different abiotic 
surfaces (e.g. beds, treatment tables, sinks) and the hands of patients and sanitary staff (Dziri 
et al., 2016). Eleven and two ESBL isolates were identified as K. pneumoniae and K. oxytoca, 
respectively. All the Klebsiella isolates recovered, harboured the blaCTX-M-15 gene. Other β-
lactamase genes detected include blaTEM-1, blaSHV-11, blaSHV-28, blaSHV-1 and blaSHV-12 (Dziri et 
al., 2016).  
 
1.9.1.2 Carbapenemases 
Carbapenems were initially used to treat infections caused by ESBL-producing bacteria. 
However, carbapenem resistance has been detected (Martin & Bachman, 2018; Navon-Venezia 
et al., 2017). Resistance is mainly through the acquisition of plasmid-borne carbapenemases 
which hydrolyse all β-lactams, including carbapenem (Martin & Bachman, 2018; Navon-




carbapenemase (KPC) enzyme classified under class A (Martin & Bachman, 2018; Navon-
Venezia et al., 2017).  
Class B consists of zinc-dependent carbapenemases such as the plasmid-encoded New Delhi 
metallo-β-lactamases-1 (NDM-1) enzyme (Martin & Bachman, 2018). Other enzymes of class 
B are Verona-integron metallo-β-lactamases (VIM) and imipenemase (IMP). The genes that 
encode these two enzymes are located on integrons inserted into the chromosome or carried on 
plasmids. Lastly, OXA-48 is a plasmid-encoded enzyme belonging to class D (Martin & 
Bachman, 2018).  
Three different hospitals located in Iran recovered 37 K. pneumoniae isolates from hospital 
surfaces and equipment in the intensive care unit (ICU) (Moghadampour et al., 2018). Thirty-
four isolates exhibited high resistance to carbapenem antibiotics, and the most frequently 
identified carbapenem resistance genes amongst these isolates was the blaOXA-48 gene followed 
by blaNDM and then blaIMP. The carbapenem-resistant K. pneumoniae isolates also harboured 
several ESBL encoding genes such as blaSHV, blaTEM and blaCTX-M, in high frequencies 
(Moghadampour et al., 2018). This study highlighted that surfaces in the hospital environment 
could harbour highly resistant K. pneumoniae. Therefore, it is essential to ensure that IPC 
measures regarding the disinfection of surfaces and equipment are implemented efficiently 
(Moghadampour et al., 2018).  
 
1.9.1.3 AmpC β-lactamases 
Class C enzymes are known as AmpC β-lactamases and confer resistance to penicillins, β-
lactam/β-lactamases inhibitor combinations as well as first, second and third-generation 
cephalosporins (Drawz & Bonomo, 2010). The most commonly detected blaAmpC gene families 
in K. pneumoniae are CMY, DHA, FOX and MOX types whereas infrequently detected gene 
families include ACT, MIR, ACC and LAT (Navon-Venezia et al., 2017).  
 
1.9.2 Aminoglycosides 
Aminoglycosides have been actively used in clinical settings since the 1940s. This class is 
highly effective against species belonging to the Enterobacteriaceae family such as K. 
pneumoniae (Krause et al., 2016). Despite the clinical success, aminoglycosides are associated 




Aminoglycosides bind to the A-site situated on the 16S rRNA of the 30S ribosome, thereby 
obstructing protein synthesis (Krause et al., 2016). Several resistance mechanisms have been 
described in bacteria; however, enzymatic inactivation of the antibiotic is the most popular in 
clinical settings (Ramirez & Tolmasky, 2010). 
 
1.9.2.1 Modification of antibiotic using enzymes  
The structure of aminoglycosides consists of several exposed amino and hydroxyl groups, 
making them prone to modification by enzymes known as aminoglycoside modifying enzymes 
resulting in high-level resistance (Blair et al., 2015). The modification of the antibiotic by these 
enzymes prevents the antibiotic from effectively binding to the target site, thus rendering the 
antibiotic ineffective at disrupting protein synthesis (Blair et al., 2015; Krause et al., 2016). 
Currently, more than 100 enzymes discovered are classified into three families (Krause et al., 
2016). Most of the enzymes belong to the aminoglycoside N-acetyltransferase (AAC) family, 
and they acetylate amino groups found at different positions on the aminoglycoside structure 
(Krause et al., 2016). Enzymes capable of phosphorylating hydroxyl groups form part of the 
aminoglycoside O-phosphotransferase (APH) family. Lastly, aminoglycoside O-
nucleotidyltransferase (ANT) is the smallest group of enzymes, and they adenylate hydroxyl 
groups (Krause et al., 2016).  
A study conducted in Egypt detected various genes encoding aminoglycoside modifying 
enzymes amongst K. pneumoniae isolates obtained from clinical samples (El-Badawy et al., 
2017). The most frequently observed gene was aac(6')-II followed by aac(3')-II, aph(3')-IV and 
ant(3'')-I. These genes were mostly noted in isolates showing reduced susceptibility to 
gentamicin and amikacin (El-Badawy et al., 2017).  
 
1.9.2.2 Modification of target sites 
Different bacteria can express enzymes known as 16S rRNA methylases (Navon-Venezia et 
al., 2017). Such enzymes methylate different nucleotides in the A site of the 16S rRNA, thus 
hindering the antibiotic from binding to its target site (Garneau-Tsodikova & Labby, 2016; 
Krause et al., 2016). An example of a plasmid-borne gene encoding this type of enzyme is 
armA (Krause et al., 2016; Navon-Venezia et al., 2017), observed in a study involving the 





1.9.3 Quinolones and fluoroquinolones 
Quinolones and fluoroquinolones are a group of clinically relevant antibiotic agents that consist 
of four generations. Ciprofloxacin, a second-generation fluoroquinolone, is one of the most 
frequently used (Correia et al., 2017; Redgrave et al., 2014). As a result, it is classified as a 
crucial antibiotic by the WHO. Overall, fluoroquinolones are used globally due to their 
potency, oral bioavailability and effectiveness against both Gram-positive and Gram-negative 
bacteria (Correia et al., 2017; Redgrave et al., 2014). 
DNA supercoiling is an important process carried out by DNA gyrase and topoisomerase IV. 
Quinolones and fluoroquinolones act by disrupting these two crucial enzymes (Correia et al., 
2017; Redgrave et al., 2014). The subunits that form DNA gyrase are encoded by the gyrA and 
gyrB genes. Whereas, topoisomerase IV constitutes of subunits coded by parC and parE genes 
(Cattoir & Nordmann, 2009).  
 
1.9.3.1 Mutations in genes that encode the target enzymes 
The genes encoding DNA gyrase and topoisomerase IV have a short segment of DNA known 
as the quinolone resistance determining region (QRDR), where mutations take place (Redgrave 
et al., 2014). These mutations cause amino acid substitutions resulting in structural changes in 
the target, thus altering the antibiotic's ability to bind to the enzymes. This action results in 
high-level resistance to fluoroquinolones (Redgrave et al., 2014). In K. pneumoniae, mutations 
commonly occur in gyrA and parC compared to gyrB and parE (Navon-Venezia et al., 2017).  
 
1.9.3.2 Protection proteins 
Plasmid-mediated quinolone resistance (PMQR) genes usually result in low-level resistance 
(Correia et al., 2017). An example is the qnr genes encoding proteins that protect the target 
enzymes, thus preventing quinolones from inhibiting (Blair et al., 2015; Navon-Venezia et al., 
2017). QnrA and qnrB genes were first described in K. pneumoniae strains derived from the 
United States of America (USA) and India, respectively (Jacoby et al., 2006; Navon-Venezia 





1.9.3.3 Enzymatic inactivation 
The aac(6')-Ib-cr gene is another type of PMQR gene observed in K. pneumoniae, encoding 
an enzyme known as AAC(6')-Ib-cr. This variant enzyme differs from the original AAC(6')-Ib 
enzyme as it has two distinct amino acid substitutions (Correia et al., 2017; Machuca et al., 
2016; Navon-Venezia et al., 2017). Unlike the original enzyme that only confers resistance to 
aminoglycosides, the variant enzyme can confer resistance to both aminoglycosides and two 
fluoroquinolones: ciprofloxacin and norfloxacin (Machuca et al., 2016; Navon-Venezia et al., 
2017). The structure of these two fluoroquinolones enables the variant enzyme to acetylate the 
antibiotics resulting in decreased activity (Correia et al., 2017; Navon-Venezia et al., 2017).  
 
1.9.3.4 Efflux pumps 
Another two PMQR genes reported are qepA and oqxAB encoding efflux pumps that remove 
quinolones from bacterial cells (El-Badawy et al., 2017). The efflux pump encoded by the 
former gene only reduces susceptibility to certain fluoroquinolones. In comparison, the efflux 
pump coded by the latter gene confers resistance to quinolones, tetracycline, chloramphenicol 
and trimethoprim (Correia et al., 2017; El-Badawy et al., 2017).  
In India, a study found that most K. pneumoniae isolates retrieved from clinical samples 
displayed resistance to ciprofloxacin and levofloxacin (Dehnamaki et al., 2020). This 
phenotypic resistance was attributable and significantly (p<0.05) associated with the molecular 
amplification of the oqxA and oqxB genes. Notably, the qepA gene was detected at a lower 
prevalence amongst isolates and only showed significant (p<0.05) association with the 
levofloxacin resistance phenotype. Overall, the study demonstrated that these efflux pumps 
could play a role in quinolone resistance in K. pneumoniae (Dehnamaki et al., 2020). 
 
1.9.4 Tetracycline 
Tetracycline is an antibiotic class first introduced in the 1940s. Antibiotics belonging to this 
class are broad-spectrum and are commonly used therapeutically (Roberts, 2003; Shankar et 
al., 2017). Apart from clinical usage, tetracycline has also been used extensively worldwide in 
the animal industry as growth promoters as well as for therapeutic and prophylaxis treatment 
(Kang et al., 2018). The extensive usage in both humans and animals is dangerous because it 




Tetracyclines disrupt protein synthesis by binding to the 16S rRNA of the 30S ribosomal 
subunit, thus preventing aminoacyl-t-RNA from binding to the A site located on the ribosome 
(Adesoji et al., 2015; Markley & Wencewicz, 2018). Bacteria have developed and acquired 
resistance mechanisms to tetracycline. Efflux pumps are one of the most commonly detected 
mechanisms in human pathogens (Markley & Wencewicz, 2018). Overall, most of the tet genes 
are located on plasmids, transposons, conjugative transposons and integrons (Shankar et al., 
2017).  
There are 30 different tetracycline specific efflux pumps (Grossman, 2016).  These 46 kDa 
protein structures are membrane-bound and responsible for removing antibiotics from the cell. 
As a result, the antibiotic concentration in the bacterium is never high enough to cause 
detriment (Santajit & Indrawattana, 2016; Shankar et al., 2017). The 30 different efflux pumps 
are categorised into seven different groups. Group one and group two efflux pumps are the 
most prevalent in clinical settings (Grossman, 2016). Group one contains several pumps 
commonly detected in Gram-negative bacteria, however, the Tet (A) and Tet (B) pumps 
encoded by the tetA and tetB genes respectively, are the most frequently encountered 
(Grossman, 2016; Shankar et al., 2017). These aforementioned genes have been described in 
Klebsiella (Roberts & Schwarz, 2016). Alternatively, group two contains Tet (K) and Tet (L) 
pumps, commonly found in Gram-positive bacteria (Grossman, 2016; Shankar et al., 2017).  
 
1.9.5 Phenicols 
Chloramphenicol is used sparingly in developing countries to treat serious infections when 
antibiotic treatment options are limited. This antibiotic is not used in developed countries due 
to the adverse effects, such as fatal aplastic anaemia (Čivljak et al., 2014). Its action mechanism 
is based on inhibiting protein synthesis by binding to the peptidyl transferase cavity of the 23S 
rRNA of the 50S ribosomal subunit (Kapoor et al., 2017; Schwarz et al., 2004).  
 
1.9.5.1 Enzymes that inactivate antibiotics 
The enzyme chloramphenicol acetyltransferase (CAT) is encoded by the cat gene. This enzyme 
can acetylate chloramphenicol, thereby inactivating it and hindering binding to the target site 
(Huang et al., 2017; Yoneyama & Katsumata, 2006). There are two different types of CAT 
enzymes, namely, CAT-A and CAT-B, encoded by different genes. Generally, the genes catA1, 




Enterobacteriaceae family and have been noted in Klebsiella species (Roberts & Schwarz, 
2016; Williams et al., 2019).  
 
1.9.5.2 Efflux transporters 
Several efflux pumps are effective at exporting chloramphenicol out of the bacterial cell. Efflux 
pumps encoded by the cmlA1 and floR genes have been described in Klebsiella (Roberts & 
Schwarz, 2016).  
 
1.9.6 Folate pathway inhibitors 
Since 1968, sulfamethoxazole and trimethoprim have been used in combination, to treat UTIs, 
enteric bacterial infections and respiratory tract infections (Frank et al., 2007; Manyahi et al., 
2017). This antibiotic combination is known as cotrimoxazole, and each antibiotic disrupts a 
different enzyme involved in distinct steps in the folic acid pathway (Frank et al., 2007; 
Huovinen, 2001). Sulfamethoxazole inhibits dihydropteroate synthase (DHPS) whereas 
trimethoprim inhibits dihydrofolate reductase (DHFR). Although resistance can happen in 
various ways, in Gram-negative enteric bacteria, acquisition of drug-resistant enzymes is the 
most common mechanism (Frank et al., 2007; Manyahi et al., 2017).  
Resistance is gained by acquiring genes that encode enzymes that are naturally resistant to the 
antibiotics, thus making them ineffective (Frank et al., 2007). These modified enzymes (DHFR 
and DHPS) are encoded by the dfr and sul genes for trimethoprim and sulfamethoxazole, 
respectively (Manyahi et al., 2017). More than 30 dfr genes have been described compared to 
only three sul genes (Shin et al., 2015). Amongst species within the Enterobacteriaceae family, 
the dfr and sul1 genes are associated with class 1 integrons that may be present on plasmids, 
transposons or the chromosome. The sul2 gene is found on small non-conjugative plasmids or 
large conjugative plasmids (Manyahi et al., 2017). Lastly, the rarely detected sul3 gene is 
located on plasmids (Shin et al., 2015).  
Genes encoding these modified enzymes have been detected in K. pneumoniae. For instance, 
D'Souza et al. (2019) conducted a study involving two tertiary hospitals in Pakistan and USA. 
The sampling of five different surfaces (light switch, nurses call button, sink handles, bed-side 




was only present in samples from Pakistan, and these isolates harboured the sul1, sul2, dfrA27 
and dfrA12 resistance genes (D'Souza et al., 2019).  
 
1.10 The different molecular typing methods used for K. pneumoniae 
Typing methods are employed to differentiate bacterial isolates belonging to the same species 
(Foxman et al., 2005). The application of these tools can help describe the sources and routes 
of bacterial transmission and identify pathogenic strains or clones. This is essential when 
investigating outbreaks and performing infectious disease-related surveillance studies (Van 
Belkum et al., 2007). Initially, the differences between isolates were evaluated using 
phenotypic characteristics based on results obtained from biotyping, serotyping and antibiotic 
susceptibility testing (Singh et al., 2006). However, due to the inability to differentiate between 
closely related strains, these phenotypic methods have been replaced with genotypic ones that 
focus on the genetic content of bacteria (Li et al., 2009). None of the genotypic methods are 
designated as universally ideal (Li et al., 2009). Instead, their performance is evaluated based 
on typeability, discriminatory power, reproducibility and convenience (Van Belkum et al., 
2007).  
Typeability refers to the ability to produce results that can be interpreted, whereas 
discriminatory power is based on the ability to differentiate between genetically unrelated 
isolates (Foley et al., 2009; Van Belkum et al., 2007). Reproducibility is the ability to obtain 
the same result if the experiment is repeated at a different time and place. The convenience 
criteria is based on several factors such as costs involved, time taken to generate results and 
resources required. The resource component includes the skills necessary to execute the test 
and the required reagents and equipment (Foley et al., 2009; Van Belkum et al., 2007).  
 
1.10.1 Repetitive sequence-based polymerase chain reaction 
Throughout the bacterial genome, several dispersed repeated DNA sequences can be used for 
molecular typing. The different repeat sequences have unique complementary primers to 
amplify fragments between the repetitive sequences (Li et al., 2009). There are three types of 
repeat sequences: the enterobacterial repetitive intergenic consensus (ERIC) sequence, the 
repetitive extragenic palindromic (REP) sequence and the BOX sequence. Depending on the 
target repeat sequence, the procedure is named ERIC-PCR, REP-PCR and BOX-PCR (Foley 




separate the fragments according to size. The resulting banding pattern formed is used to 
differentiate between isolates (Foley et al., 2009; Li et al., 2009).  
There are several advantages associated with the above-mentioned PCR-based typing methods. 
Firstly, outcomes are generated in a short space of time (Foley et al., 2009). Secondly, the 
technique is able to differentiate between two closely related strains (Hashemi & Baghbani-
Arani, 2015). Lastly, the procedure is not labour intensive and the different materials required 
are of low cost (Li et al., 2009). However, the reproducibility is low because the banding 
patterns formed may vary depending on the protocol, equipment and reagents used (Foley et 
al., 2009; Foxman et al., 2005). Nonetheless, PCR-based methods are beneficial because they 
serve as an excellent feature for research purposes and can be used to support pulsed-field gel 
electrophoresis (PFGE) in reference centres (Neoh et al., 2019).  
Otman et al. (2002) aimed to investigate the genetic relationship between Klebsiella isolates 
recovered from an outbreak in the neonatal ICU (NICU) ward of a healthcare facility situated 
in Brazil. Seventeen isolates were collected from May 1998 to March 1999. ERIC-PCR 
revealed that 14 isolates were 100% similar thus clustered (designated as cluster E1) together 
on the dendrogram (Otman et al., 2002). These identical isolates were derived from patients 
and one staff member. The remaining three isolates, which clustered together to form cluster 
E2 were obtained from one unspecified environmental source and patients. All isolates from 
E2 shared more than 90% similarity with isolates from E1 (Otman et al., 2002). This study 
suggested that clonally related isolates were involved in the outbreak.  
 
1.10.2 Pulsed-field gel electrophoresis  
PFGE utilises specific enzymes to cut chromosomal DNA (Singh et al., 2006). These enzymes 
have uncommon recognition sites; thus, the DNA will be cleaved less frequently, resulting in 
the formation of large DNA fragments (Li et al., 2009). The fragments generated range between 
20-600 kb. Thus, they cannot be separated using conventional gel electrophoresis which utilises 
a unidirectional electrical current (Adzitey et al., 2013; Singh et al., 2006; Van Belkum et al., 
2007). Instead, the electric field's direction across the gel is changed periodically (Singh et al., 
2006). The resulting banding pattern is analysed and compared between isolates (Foley et al., 
2009). Although PFGE has moderate to high reproducibility and discriminatory power, it is 




four days. Furthermore, the costs associated with this technique are high due to the equipment 
and supplies needed (Foley et al., 2009; Foxman et al., 2005; Van Belkum et al., 2007).  
During 2001, a university hospital situated in New York City reported an outbreak of ESBL-
producing K. pneumoniae affecting infants in the NICU (Gupta et al., 2004). Using PFGE, the 
outbreak strain (clone A) was found to be genetically similar to surveillance cultures obtained 
from a stethoscope and the hands of two healthcare practitioners working within the affected 
ward. The affected healthcare workers either had artificial nails or a professional manicure 
coupled with a long nail length. No positive cultures were obtained after removing artificial 
nails and reducing the length of the nails (Gupta et al., 2004).  
 
1.10.3 Multilocus sequence typing 
Bacteria have specific housekeeping genes that can be used in multilocus sequence typing 
(MLST) (Foley et al., 2009). The commonly used genes for K. pneumoniae when performing 
this technique include rpoB, phoE, gapA, tonB, mdh, infB and pgi (Diancourt et al., 2005). 
MLST uses DNA sequencing to identify any genetic polymorphisms present in the sequence 
of each gene. Every unique sequence detected in a gene is given a number. Thus, each isolate 
will have a seven-numbered allelic profile representing the sequence type (ST) (Li et al., 2009; 
Singh et al., 2006). When isolates are the same ST or have the same allelic profile, they are 
regarded as clonally related (Foley et al., 2009).  
MLST has high reproducibility and repeatability. Furthermore, the discriminatory power 
ranges from moderate to high, depending on the genes chosen (Foxman et al., 2005). However, 
since multiple genes need to be sequenced, MLST is very time-consuming and expensive (Li 
et al., 2009). The housekeeping genes used in MLST are often highly conserved and do not 
undergo rapid genetic changes, which is advantageous when conducting phylogenetic studies. 
However, this may be also problematic as the genetic variation between two closely related 
strains may not be detected (Foley et al., 2009; Li et al., 2009).  
Between January 2013 and February 2014, 41 carbapenem-resistant K. pneumoniae isolates 
were collected from a Chinese tertiary hospital (Hu et al., 2016). The outbreak was linked to 
an environmental component as clonally related isolates were recovered from 13 ventilators 
and 25 patients hospitalised in different wards. All these isolates were classified as ST11 using 
MLST and clustered together (≥80% similarity) on the dendrogram obtained by PFGE (Hu et 




identical (100% similarity) to isolates derived from ventilators. The remaining three isolates 
retrieved from patients belonged to novel ST1844, novel ST1855 and ST1244. The two latter 
isolates belonging to different STs did not cluster with ST11 isolates; instead, each isolate 
clustered independently, thus demonstrating genetic unrelatedness (Hu et al., 2016).  
 
1.11 Klebsiella outbreaks in South Africa 
The most recent outbreak took place at Thelle Mogoerane regional hospital situated in 
Vorsloorus, Gauteng. The outbreak involved antibiotic-resistant K. pneumoniae and resulted 
in six infants' death between July and September 2018. An investigation was initiated, and 
several IPC measures were implemented to prevent further cross-infection (Petersen, 2018).  
In 2012, a tertiary hospital based in Cape Town described an outbreak of blaOXA-181 producing 
Klebsiella in a haematology unit. K. pneumoniae was determined as the causative species in 
seven of the eight positive cases (Jacobson et al., 2015). Investigations suggested that 
inadequate IPC measures could have resulted in the spread of Klebsiella amongst affected 
patients as healthcare workers practised poor hand hygiene. Furthermore, healthcare workers 
often breached contact precaution protocols involving the usage and appropriate disposal of 
apron and gloves when entering a patient room (Jacobson et al., 2015). 
In 2005, Mahatma Gandhi Memorial Hospital situated in Durban, KwaZulu-Natal reported an 
outbreak of ESBL-producing K. pneumoniae in the neonatal ward resulting in the fatality of 22 
infants. Investigations linked the source of the outbreak to medication, as opened vamin and 
glucose preparations were contaminated and used for multiple dosing, while unopened vials of 
the preparation remained sterile (Moodley et al., 2005). The researchers suggested that a 
contaminated hand touched the rubber stoppers of the vial where the bacterium persisted. Due 
to multiple usages, an entry passage for the bacterium was established, and the bacteria thrived 
in the glucose-rich medium (Moodley et al., 2005). During the outbreak period, the affected 
hospital was understaffed and had insufficient sinks and space, which adversely affected the 
implementation of IPC measures. The banning of multiple dosing and emphasising good hand 
hygiene helped eradicate the outbreak (Moodley et al., 2005).  
Coovadia et al. (1992) described an outbreak of amikacin and cephalosporin-resistant K. 
pneumoniae during 1989, affecting nine infants (six colonised and three infected) in a nursery 
of a hospital situated in Durban, South Africa. The outbreak strain was detected in the nose and 




et al., 1992). Furthermore, the outbreak strain was also detected from a few environmental 
sources such as bassinettes, suction apparatus, thermometers, pedal bins, wooden shelves, sinks 
and a specimen forms box. Reinforcing strict IPC measures helped terminate the outbreak 
(Coovadia et al., 1992). 
 
1.12 The dissemination of bacteria within the hospital environment 
1.12.1 The role of healthcare workers  
The most significant way bacteria can spread to patients is through the hands of healthcare 
workers, such as doctors and nurses (Hartmann et al., 2004). The hands of healthcare workers 
are in constant contact with patients; hence they can easily become colonised with bacteria 
during patient care. Once hand hygiene is ignored, bacteria will survive for a few minutes on 
the skin, which has undesirable growth conditions for Gram-negative bacteria. Klebsiella is 
considered a transient microbe, thus it can persist on the skin, but it does not multiply (Mathur, 
2011; Pittet et al., 2006; Podschun & Ullmann, 1998).  
A tertiary hospital situated in India investigated the prevalence of bacteria on the hands of 44 
doctors working in the medicine and dermatology ward (Paul et al., 2011). Upon entry into the 
wards, no Klebsiella was detected although this bacterium was later recovered from the hands 
of four doctors when they exited the wards (Paul et al., 2011). After handwashing with tap 
water and after sanitisation with alcohol swabs, the contamination was eradicated as no 
Klebsiella was detected on their hands afterwards. This study highlighted the importance of 
practising good hand hygiene as it may help reduce hand contamination which can contribute 
to disseminating bacteria (Paul et al., 2011).  
 
1.12.2 The role of the hospital environment 
The hospital environment can harbour multiple bacterial species with the ability to survive on 
surfaces for various periods (Doll et al., 2018). When a healthcare worker's hands encounter 
contaminated surfaces, they can transmit bacteria to patients if hand hygiene is disregarded. 
Patients can also become colonised with bacteria if they encounter contaminated surfaces 






Figure 1.1: The various routes of transmission in the hospital environment (CDC & ICAN, 
2019). 
Moist and soiled environments such as sinks, toilets and showering facilities, favour the growth 
and persistence of Gram-negative bacteria (Muzslay et al., 2017; Suleyman et al., 2018). 
During a non-outbreak period, a study involving 13 French ICUs was conducted to examine 
the role of handwashing sinks as a source of contamination (Roux et al., 2013). A total of 60 
ESBLs were isolated from the sink drains. Twenty-nine and four of these recovered ESBL 
isolates were identified as K. pneumoniae and K. oxytoca, respectively (Roux et al., 2013). 
Klebsiella can also survive on dry surfaces (Suleyman et al., 2018). Worku et al. (2018) 
detected Klebsiella isolates on the door handle, thermometer, floor, table-top, window handle, 
stethoscope and wall of a University hospital in Ethiopia.  
Apart from prevalence studies, Klebsiella species have been involved in outbreaks linked to an 
environmental component (wet and dry). During 2000, an outbreak of MDR ESBL-producing 
K. pneumoniae occurred in a Netherlands teaching hospital. Through environmental 
surveillance, the outbreak strain was recovered from patient transfer roller boards (Van't Veen 
et al., 2005). Using, multienzyme amplified length polymorphism (ME-AFLP), the 
environmental isolates were considered identical (90-100% similarity) to the clinical isolates 
recovered from the affected patients. The outbreak was eradicated after rigorous sterilisation 
and replacement of the roller boards (Van't Veen et al., 2005).  
A minor outbreak of ESBL-producing K. pneumoniae occurred in the neurosurgical ICU ward 
of a tertiary hospital in Sweden between 2009 to 2010 (Starlander & Melhus, 2012). The 
patients affected (colonised and infected) seemed to have shared the same room in the ICU but 
at different times. Environmental sampling of the sink plug hole followed by PFGE analysis 




(Starlander & Melhus, 2012). Further investigations showed that apart from being used to 
access clean water, the sink was also used for waste disposal. The waste disposal procedure 
was abolished to terminate the outbreak effectively. Furthermore, the sinks and plumbing 
system was replaced (Starlander & Melhus, 2012).  
 
1.13 The importance of implementing infection prevention and control measures in the 
hospital environment 
IPC measures are crucial in all healthcare facilities to ensure a safe environment for all 
individuals within (Arbee et al., 2012; Storr et al., 2017). However, several factors may 
negatively influence the implementation of IPC measures. These factors include limited 
financial resources, overcrowding, insufficient staff, inadequate medical and medicinal 
resources (Dusé, 2005).  
Five crucial elements of IPC are handwashing, isolation, disinfection, sterilisation and 
surveillance (Arbee et al., 2012). Effective hand hygiene is the most critical IPC measure 
(Loftus et al., 2019). Healthcare workers' hands may become contaminated with bacteria due 
to their exposure to patients during routine care (Allegranzi & Pittet, 2009). Furthermore, since 
the patients also shed microorganisms onto surrounding surfaces, healthcare workers' hands 
can also be contaminated upon touching these surfaces (Allegranzi & Pittet, 2009). 
Contaminated hands can spread bacteria throughout the hospital, and the only way to interrupt 
this transmission is through practising good hand hygiene (Loftus et al., 2019).  
The WHO identified five key points (see Figure 1.2) where hand hygiene needs to be practised: 
prior to patient contact, prior to performing aseptic procedures, after being exposed to bodily 
fluids, after patient contact and after encountering surfaces that surround the patient (Loftus et 
al., 2019). Generally, hand hygiene adherence is low in both developing and developed 
countries. The low compliance is due to skin irritation caused by some handwashing agents 
and lack of time resulting from overcrowding and understaffing. Lastly, the lack of or 
inconvenient position or location of sinks and handwashing agents may also result in low 





Figure 1.2: The five important points of hand hygiene in a hospital environment (Loftus et al., 
2019). 
There are also specific standard precautions that healthcare workers need to follow, such as the 
appropriate usage of gloves, gowns, and protective gear (masks, eye and face shields) (Mehta 
et al., 2014). It is essential to wear protective gear and gowns when performing patient activities 
that may generate splashes from bodily fluids. Gloves are worn when conducting aseptic 
procedures and when contact needs to be made with mucous membranes and skin that is not 
intact (Mehta et al., 2014). The gloves' surface can still become contaminated during routine 
care; therefore, it is vital to practice specific measures to prevent cross-transmission. Essential 
measures include changing gloves when moving from one site to another in the same patient 
or when moving from one patient to another. Furthermore, it is also essential to safely remove 
the gloves after usage and practising good hand hygiene after that (Loveday et al., 2014; Pittet 
et al., 2006).  
To investigate hand hygiene compliance at the five points highlighted by the WHO, a study 




and diabetic care ward of a non-specified teaching hospital (Randle et al., 2010). The results 
showed that amongst healthcare workers, hand hygiene compliance was highest prior to 
performing sterile procedures (100%), followed by after exposure to bodily fluids (92.5%) and 
after encountering a patient (80.3%). Lower hand hygiene adherence was observed before 
patient contact (67.6%) and after touching surfaces surrounding the patient (50.4%) (Randle et 
al., 2010). The latter's low compliance highlights the importance of other IPC measures such 
as environmental cleaning and the appropriate disinfection and sterilisation of equipment 
(Allegranzi & Pittet, 2009; Dusé, 2005). These measures can reduce transmission because the 
cleaning will decrease the bacterial load which will minimise the contamination of healthcare 
workers' hands (Doll et al., 2018).  
Surveillance is another important measure that can monitor antibiotic resistance patterns, assess 
current preventative measures in place and provide information regarding the status 
(prevalence, cause and type of infection) of HAIs (Ridelberg & Nilsen, 2015; Storr et al., 2017). 
Surveillance studies are neglected and poorly resourced in South Africa; hence the actual 
prevalence rate of HAIs is unknown. However, it is assumed that the burden of HAIs is more 
considerable in public healthcare facilities compared to private healthcare facilities (Lowman, 
2016). 
 
1.14 Healthcare facilities in South Africa 
The healthcare system in South Africa consists of two sectors: private and public (Modisakeng 
et al., 2020). The former sector provides services to less than 20% of the population (Mahomed 
et al., 2017). These healthcare services are funded by medical aids and out-of-pocket payments 
(Modisakeng et al., 2020). On the other hand, more than 80% of the population utilise the 
government-controlled public sector for healthcare services financed by general tax revenues 
(Modisakeng et al., 2020; Webb et al., 2019).  
Every healthcare facility within the public sector is required to follow policy guidelines 
stipulated by the National Department of Health (Gray et al., 2016). Every province in South 
Africa has its own Provincial Department of Health responsible for ensuring that healthcare 
services are adequately delivered to patients. Each province is further divided into different 
districts. A total of 52 different health districts exist across the nine provinces in South Africa 




uMgungundlovu, Uthukela, Umkhanyakude, Umzinyathi, Amajuba, Sisonke, Ugu, Uthungulu 
and Zululand (Department of Health, 2012).  
Within the public sector, various healthcare facilities are characterised into four different levels 
(Pillay & Mahomed, 2019). Level one healthcare facilities include primary healthcare (PHC) 
clinics, community healthcare (CHC) centres and district hospitals (KwaZulu-Natal 
Department of Health, 2014). PHC clinics are the first point of entry into the healthcare system. 
The services provided include immunisation, family planning, prenatal care, treatment and 
management of communicable diseases (KwaZulu-Natal Department of Health, 2014; Mofolo 
et al., 2019). Suppose the PHC clinic cannot provide the services required by the patient, a 
referral to a CHC centre will occur due to the additional services they provide such as a 24-
hour maternity service, casualty and a short stay ward. If necessary, a patient can subsequently 
be referred to a district hospital from the CHC centre (KwaZulu-Natal Department of Health, 
2014). District hospitals are designed to serve patients within a specific health district, and the 
services provided are general and include surgery, paediatrics, obstetrics and gynaecology 
(Department of Health, 2012).  
From district hospitals, patients can be referred to regional (level two), tertiary (level three), 
then central (level four) hospitals, where they can receive specialist and subspecialist services 
(Pillay & Mahomed, 2019). Regional hospitals receive referral patients from different districts 
within the same province (Department of Health, 2012). Healthcare services provided include 
orthopaedics, psychiatry, diagnostic radiology and anaesthesiology (Department of Health, 
2017).  
Both tertiary and central hospitals can receive referral patients from different provinces 
(Department of Health, 2012). Tertiary hospitals provide services such as neurology, 
cardiology and urology. Central hospitals offer services like advanced trauma care and organ 
transplants (KwaZulu-Natal Department of Health, 2014; Department of Health, 2017). Lastly, 
specialised hospitals are also classified as level four, providing special services such as 
rehabilitation, psychiatric and infectious disease (Department of Health, 2012; KwaZulu-Natal 
Department of Health, 2014). 
Overall, healthcare facilities in the public sector are faced with numerous challenges such as 
long waiting times, suboptimal implementation of IPC measures, shortage of resources, old 





1.15 Rationale of the study 
Several studies have been conducted on K. pneumoniae in hospital settings; however, most 
reviews have been clinically based. Very few studies have investigated the hospital-
environmental component, especially in South Africa where public healthcare facilities are 
faced with numerous challenges such as the implementation of IPC measures (Maphumulo & 
Bhengu, 2019). Thus, this study can assist hospital staff as it may reveal which areas are more 
prone to bacterial contamination, thus aiding in strengthening current IPC interventions. This 
can potentially reduce bacterial transmission and can impact the occurrence of HAIs which are 
an economic burden. Furthermore, this study can also examine the burden of antibiotic-
resistant K. pneumoniae in the hospital environment. This is a crucial aspect because ESBL-
producing K. pneumoniae is regarded as a critical priority microorganism by the WHO (Mulani 
et al., 2019).  
 
1.16 Aim 
• To investigate the prevalence, genetic diversity, antibiotic resistance and virulence 
profiles of K. pneumoniae recovered from frequently touched surfaces in South African 
public hospitals in a non-outbreak setting. 
 
 1.17 Objectives 
• To collect environmental samples by swabbing 11 predetermined sites in three different 
wards of four public hospitals situated in KwaZulu-Natal. 
• To use phenotypic and genotypic tools to isolate and identify K. pneumoniae from the 
collected samples.  
• To examine the antibiotic susceptibility profiles of the collected K. pneumoniae isolates 
using the Kirby-Bauer disk diffusion method.  
• To phenotypically characterise extended-spectrum β-lactamase (ESBL)-producing K. 
pneumoniae isolates using the combination disk method. 
• To screen K. pneumoniae isolates for antibiotic resistance and virulence genes using 
polymerase chain reaction (PCR).  
• To assess the clonal relatedness of the collected isolates using enterobacterial repetitive 





1.18 Study outline 
This thesis is presented according to the guidelines stipulated by the College of Health Science, 
University of KwaZulu-Natal.  
• Chapter 1 provides an in-depth review of the current information available pertaining 
to this study. It also details the aims and objectives as well as the rationale of the study.  
• Chapter 2 presents the findings of this research in manuscript format. This chapter was 
submitted to Microbial Drug Resistance (MDR-2020-0546) as follows:  
Title: Molecular surveillance and dissemination of Klebsiella pneumoniae on 
frequently encountered surfaces in South African public hospitals 
Authors: Nongcebo Z. Z. Malinga, Christiana O. Shobo, Chantal Molechan, Daniel G. 
Amoako, Oliver T. Zishiri and Linda A. Bester 
• Chapter 3 outlines the main findings, conclusions and implications, limitations and 
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Introduction: Bacteria that cause life-threatening illnesses in humans can also contaminate 
hospital surfaces, thus posing as a potential source of infection. This study aimed to investigate 
the prevalence, genetic diversity, virulence and antibiotic resistance profile of K. pneumoniae 
in KwaZulu-Natal, South Africa. 
Methods: In a non-outbreak setting involving four public hospitals, 777 samples were collected 
in three different wards from 11 different sites. Phenotypic and genotypic methods were used 
for isolation and identification. The Kirby-Bauer disk diffusion method was used to examine 
antibiotic resistance, followed by the combination disk method to characterise extended-
spectrum β-lactamases (ESBLs). Antibiotic resistance and virulence genes were screened using 
polymerase chain reaction (PCR) and clonality was investigated using enterobacterial 
repetitive intergenic consensus (ERIC)-PCR.  
Results: Seventy-five (10%) K. pneumoniae isolates were recovered. These isolates were 
obtained from all four hospitals and all three wards involved. However, only six frequently 
touched surfaces were contaminated. These sites included the occupied beds, sinks, mops, 
unoccupied beds, patient files and blood pressure (bp) monitors. Thirty (40%) isolates were 
characterised as ESBLs showing high resistance to antibiotics and mostly harbouring the 
blaCTX-M group one gene. Virulence genes were highly prevalent amongst all the isolates. 
ERIC-PCR showed that the isolates recovered from different sites within the same hospital 
were genetically similar.  
Conclusion: The study demonstrated that K. pneumoniae can contaminate various surfaces 
and this persistence allows for the dissemination of bacteria within the public hospital 
environment when infection prevention and control (IPC) measures are substandard. The 
information from this study can help hospitals evaluate and improve interventions in place to 
limit the spread of bacteria. 
Keywords: Klebsiella pneumoniae; extended-spectrum β-lactamases; virulence; hospital 






2.1 Introduction  
Hospital-acquired infections (HAIs) are infections that occur in a patient while receiving 
medical care at a healthcare facility. However, HAIs are not initially present when the patient 
is first admitted; thus, symptoms only appear 48 hours or more after admission or within 30 
days of being discharged (Haque et al., 2018; Khan et al., 2017). HAIs are of global concern; 
hence, in the United States of America (USA) and Europe, prevalence rates are at 4.5% and 
7.1%, respectively (Phu et al., 2016). Due to limited resources, the true burden is unestablished 
in South Africa; however, there are anecdotal reports suggesting that HAIs are more prevalent 
in public healthcare facilities than private healthcare facilities (Lowman, 2016). Nonetheless, 
HAIs are associated with increased morbidity and mortality (Ali et al., 2018). Furthermore, 
due to the prolonged hospital stay and the need for additional treatment and diagnostic tests, 
HAIs increase healthcare costs (Nair et al., 2018). A large proportion of HAIs are caused by 
bacteria (Khan et al., 2017). Notably, Klebsiella pneumoniae is one of the six bacterial species 
that commonly cause HAIs (Santajit & Indrawattana, 2016).  
Many factors influence a patient's risk of acquiring an infection (Nair et al., 2018). Patients 
who suffer from other underlying conditions such as diabetes and those who have recently 
undergone medical procedures such as surgery are more vulnerable to infections (Nair et al., 
2018). Studies have also indicated that a contaminated hospital environment can play a role in 
transmitting bacteria since medical equipment such as blood pressure cuffs and housekeeping 
surfaces such as bedrails can harbour bacteria (Suleyman et al., 2018). Research has 
demonstrated that the survival period of Klebsiella species on dry surfaces is usually between 
two hours and more than 30 months. This persistence is influenced by humidity, temperature, 
inoculum size, surface and strain type (Suleyman et al., 2018). 
Once the hands of healthcare workers encounter contaminated surfaces, they can transmit 
bacteria to patients during patient care if hand hygiene protocols are not strictly adhered to. 
Thus, contaminated hands either from the environment or from direct contact with infected or 
colonised patients cause 30-40% of the HAIs that occur (Doll et al., 2018; Suleyman et al., 
2018). Infection prevention and control (IPC) measures implemented in healthcare facilities 
aim to reduce the chances of developing an HAI (Lee et al., 2019). Practising good hand 
hygiene and effectively cleaning surfaces are critical measures that can decrease the bacterial 
load, thus reducing any chances of bacterial transmission (Doll et al., 2018; Loftus et al., 2019; 




The Klebsiella genus consists of Gram-negative species that fall under the Enterobacteriaceae 
family (Barrios-Camacho et al., 2019). K. pneumoniae can cause various infections such as 
pneumonia, urinary tract infections (UTIs) and bloodstream infections (Martin & Bachman, 
2018). These infections are more challenging to treat when antibiotic-resistant bacteria are 
involved (Paczosa & Mecsas, 2016). K. pneumoniae can acquire antibiotic resistance genes 
encoding extended-spectrum β-lactamases (ESBLs), which confer resistance to important β-
lactam antibiotics such as third-generation cephalosporins and monobactams (Paczosa & 
Mecsas, 2016; Zeynudin et al., 2018). The three prominent β-lactamase enzyme families are 
CTX-M, SHV and TEM, encoded by the blaCTX-M, blaSHV and blaTEM genes, respectively 
(Ojdana et al., 2014). K. pneumoniae also has four well-established virulence factors. These 
include the capsule, lipopolysaccharide, siderophores and pili (Martin & Bachman, 2018). 
In South Africa, less than 20% of individuals rely on the well-resourced private sector to 
provide healthcare; thus, a vast majority rely on the under-resourced public sectors (Mahomed 
et al., 2017). The public healthcare system consists of four different levels that cater to various 
services. District hospitals are level one, and they provide general services to patients. When 
necessary, a patient can be referred to a regional (level two), tertiary (level three) or central 
(level four) hospital for specialist and subspecialist services (Pillay & Mahomed, 2019). In 
South Africa, there is insufficient data investigating the bacterial contamination of surfaces and 
equipment within the hospital environment. Given this information, the aims of this study were 
two-fold. Firstly, to examine the prevalence of K. pneumoniae on inanimate surfaces in South 
African public hospitals.  Secondly, to determine the genetic diversity, antibiotic resistance and 
virulence profiles of the collected isolates. 
 
2.2 Materials and methods 
2.2.1 Ethical considerations 
Ethical clearance to execute this study was granted by the Biomedical Research Ethics 
Committee at the University of KwaZulu-Natal (Reference number: BE 606/16). The study 
was registered on the Health Research and Knowledge Management (Reference number: 
KZ2017RP24 630) database as required by the Department of Health, South Africa. 





2.2.2 Sampling sites 
Four public hospitals situated in the eThekwini District of KwaZulu-Natal (South Africa) 
participated in this study. For confidentiality purposes, the different hospitals are denoted as 
A, B, C and D. Furthermore, the information on each hospital detailed below was obtained 
from two National Health Act documents which outline the regulation of hospital categories 
(Department of Health, 2012) and the National Health insurance policy (Department of Health, 
2017). Hospital A and hospital B are large, with bed sizes ranging between 800-850 and 900-
950, respectively. Hospital A is classified as a central hospital containing highly complex 
equipment. As a result, it can provide sub-specialist and super-specialist services, such as 
advanced trauma care and organ transplants. Hospital B is a tertiary hospital offering 
sophisticated diagnostic and treatment services. Hospital C and hospital D are smaller, with 
bed sizes ranging between 500-550 and 550-600, respectively. Hospital C is a regional hospital 
that provides general specialists services in psychiatry, internal medicine, obstetrics and 
gynaecology, orthopaedic, general surgery, radiology and pathology. Hospital D is a district 
hospital providing general services such as surgical interventions and emergency services. 
 
2.2.3 Sample collection  
In a non-outbreak setting, a total of 777 samples were collected over three months (September 
- November 2017). Each hospital was sampled before noon once a month on one specific day 
of the week. Three wards per hospital were selected for sampling, namely the intensive care 
unit (ICU), general and paediatrics. A total of 11 predetermined frequently touched sampling 
sites were included in the study namely the patient file, sink, mop, occupied bed (the medical 
history of the patient occupying the bed was unknown), unoccupied bed (no patient was 
assigned to that bed before sampling, therefore, it was vacant), blood pressure (BP) monitor, 
nurse's table, drip stand, telephone, ventilator and the linen room door handle. Amies Agar gel 
transport swabs (Thermo Fisher Scientific, Waltham, USA) were used to sample ~ 10 cm of 
the area of interest. The swabs were placed back into the transport media and transported in 
cooler containers filled with icepacks to the laboratory and processed within four hours after 
collection. The swabs collected were immersed in 15 ml of tryptic soy broth (Oxoid, 
Basingstoke, United Kingdom) and incubated. All incubations (Shel lab incubator, Sheldon 





2.2.4 Isolation and preliminary identification 
After incubation, 30 µl of the sample was spread plated onto HiCrome Klebsiella selective agar 
base supplemented with Klebsiella selective supplement (both from HiMedia Laboratories, 
Mumbai, India). After incubation, the presumptive purple mucoid colonies formed from each 
plate were sub-cultured onto MacConkey Agar (Oxoid, Basingstoke, United Kingdom). 
Following incubation, the pink mucoid lactose fermenting presumptive colonies formed were 
sub-cultured onto nutrient agar (Oxoid, Basingstoke, United Kingdom) and incubated. The 
resulting mucoid colonies formed were subjected to several biochemical tests namely catalase 
(Catalase reagent, Clinical Sciences Diagnostic, Johannesburg, South Africa), oxidase 
(Oxidase strips, Oxoid, Basingstoke, United Kingdom), motility (Edwards and Ewing Motility 
Medium, HiMedia Laboratories, Mumbai, India) and triple sugar iron agar (Oxoid, 
Basingstoke, United Kingdom) test. Further bacterial identification was conducted using  
analytical profile index (API) 20E (bioMérieux, Marcy-l'Étoile, France) kits. The presumptive 
K. pneumoniae isolates were subsequently stored at -80 °C in tryptic soy broth (Oxoid, 
Basingstoke, United Kingdom) containing 10% glycerol (VWR International, Radnor, USA). 
K. pneumoniae American Type Culture Collection (ATCC) BAA-1705 was used for quality 
control purposes.  
 
2.2.5 Deoxyribonucleic acid extraction and molecular confirmation 
Stored stock cultures were plated onto nutrient agar (Oxoid, Basingstoke, United Kingdom) 
and incubated. After incubation, approximately three to five single colonies formed were 
suspended into 300 µl of 1X Tris-EDTA (TE) buffer (Thermo Fisher Scientific, Waltham, 
USA). This bacterial suspension was gently vortexed (DLAB MX-S Vortex Mixer, DLAB 
Scientific, Beijing, China) for 10 seconds and thereafter subjected to deoxyribonucleic acid 
(DNA) extraction using the conventional boiling method following the protocol stipulated by 
Reddy and Zishiri (2017). The DNA concentration and purity were assessed using the 
Nanodrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, USA). The 
extracted DNA was considered pure when the 260/280 ratio ranged between 1.8-2.0, 
subsequently leading to storage at -20 °C for further downstream applications. Using the 
extracted genomic DNA, the polymerase chain reaction (PCR) for the amplification of the the 
khe gene (encoding haemolysin) was used to detect K. pneumoniae (Jian-Li et al., 2017; Yin-
Ching et al., 2002). The PCR was carried out using a T100TM Thermal Cycler (Bio-Rad, 




µl, and it consisted of 12.5 µl DreamTaq PCR master mix (2X) (Thermo Fisher Scientific, 
Waltham, USA), 5.5 µl nuclease-free water (Thermo Fisher Scientific, Waltham, USA), 5 µl 
template DNA and 1 µl of each primer (working stock concentration of 10 µM). All primers 
were purchased from Inqaba Biotechnical Industries (Pty) Ltd, Pretoria, South Africa. The 
resulting PCR products were loaded into 1.5% (w/v) agarose (SeaKem LE Agarose, Lonza 
Bioscience, Basel, Switzerland) gel stained with ethidium bromide (Thermo Fisher Scientific, 
Waltham, USA) and subjected to gel electrophoresis (Bio-Rad, Hercules, USA) at 60 V for 90 
minutes using 0.5X Tris-borate-EDTA (TBE) buffer (Thermo Fisher Scientific, Waltham, 
USA). A 100 bp DNA ladder (New England Biolabs, Ipswich, USA) was used as a molecular 
weight marker. The results were visualised using the ChemiDoc imaging system (Bio-Rad, 
Hercules, USA). K. pneumoniae ATCC BAA-1705 served as a positive control. All the PCR 
reactions conducted in this study included a negative control using nuclease-free water 
(Thermo Fisher Scientific, Waltham, USA) instead of template DNA.   
 
2.2.6 Antibiotic susceptibility testing 
Antibiotic susceptibility testing was performed on all the PCR confirmed K. pneumoniae 
isolates using the Kirby-Bauer disk diffusion method on Mueller Hinton Agar (Oxoid, 
Basingstoke, United Kingdom) as per Clinical Laboratory Standards Institute guidelines 
(CLSI, 2017). A total of 12 antibiotics belonging to seven different classes were screened. 
These include antibiotics from the β-lactam class: ampicillin (10 µg), cefazolin (30 µg), 
cefoxitin (30 µg), ceftriaxone (30 µg), meropenem (10 µg) and amoxicillin-clavulanate (20/10 
µg); the aminoglycosides class: gentamicin (10 µg); the fluoroquinolone class: ciprofloxacin 
(5 µg); the tetracycline class: tetracycline (30 µg); the folate pathway inhibitors class: 
trimethoprim-sulfamethoxazole (1.25/23.75 µg); the phenicols class: chloramphenicol (30 µg); 
and lastly the nitrofurans class:  nitrofurantoin (300 µg) (Oxoid, Basingstoke, United 
Kingdom). Escherichia coli ATCC 25922 was used for quality control purposes. The results 
were interpreted according to the CLSI guidelines (CLSI, 2017). Isolates were classified 
multidrug-resistant (MDR) when they showed resistance to at least one antibiotic in three or 





2.2.7 Phenotypic detection of extended-spectrum β-lactamase producers 
The isolates resistant to ceftriaxone (CLSI, 2017) were subjected to the ESBL test per the CLSI 
guidelines (CLSI, 2017). The combination disc method was performed on Mueller-Hinton 
Agar (Oxoid, Basingstoke, United Kingdom) using discs (D67C MAST Discs, Mast Group, 
Bootle, United Kingdom) of ceftazidime (30 µg) and cefotaxime (30 µg) alone and in 
conjunction with clavulanate (10 µg). Results were interpreted according to the CLSI 
guidelines (CLSI, 2017). K. pneumoniae ATCC 700603 and E. coli ATCC 25922 were used 
as a positive and negative control, respectively.  
 
2.2.8 Identification of virulence and antibiotic resistance genes 
PCR was used to detect β-lactamase (blaTEM, blaSHV, blaCTX-M group one), aminoglycoside 
[aac(3')-II, aac(6')-Ib] and fluoroquinolone (qnrB) associated resistance genes.  Virulence 
genes encoding type three pili (mrkD), siderophore (entB) and lipopolysaccharide (wabG) were 
also screened using PCR. All the PCR conditions used are outlined in Table 2.1. Singleplex 
(entB, blaTEM, blaSHV) reactions were conducted in the volumes previously described above in 
section 2.2.5. All the multiplex reactions were made to a total volume of 25 µl comprised of 
12.5 µl DreamTaq PCR master mix (2X) (Thermo Fisher Scientific, Waltham, USA) and 5 µl 
of DNA. The primer (working stock concentration of 10 µM) volumes differed in each reaction 
and they were as follows respectively: mrkD and wabG, 0.5 µl and 1 µl; blaCTX-M group 1 and 
aac(3')-II, 1.5 µl and 1 µl; qnrB and aac(6')-Ib, 1.5 µl and 0.5 µl. Nuclease-free water (Thermo 
Fisher Scientific, Waltham, USA) was added in different volumes to the different reactions to 
make up the total volume. For quality control purposes the following positive controls were 
used: K. pneumoniae ATCC BAA-1705 for the virulence genes, K. pneumoniae strain 3_S2 
(accession number: LJDW00000000) for qnrB and aac(6')-Ib and K. pneumoniae strain 15_S8 
(accession number: LJEC00000000) was used for all the remaining antibiotic resistance genes. 





Table 2.1: The expected amplification size, primer sequences and PCR conditions for the identification, virulence and antibiotic resistance genes 
utilised in this study.  
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2.2.9 Investigating genetic diversity using enterobacterial repetitive intergenic consensus 
polymerase chain reaction 
Representative isolates were subjected to enterobacterial repetitive intergenic consensus 
polymerase chain reaction (ERIC-PCR) to assess clonality. Using pure cultures, 48 isolates 
were subjected to genomic DNA extraction using the Quick DNA Fungal/Bacterial Miniprep 
kit (Zymo Research, Irvine, USA) following the manufacturer's instructions. The extracted 
genomic DNA was quantified and assessed for purity using the conditions previously specified 
in section 2.2.5.  The extracted DNA was utilised to conduct ERIC-PCR using a T100TM 
Thermal Cycler (Bio-Rad, Hercules, USA). The following PCR conditions were applied: 2 
minutes of initial denaturation at 95 °C, 34 cycles of 30 seconds of denaturation at 90 °C, 1 
minute of annealing at 52 °C, 8 minutes of extension at 65 °C, and a final elongation of 16 
minutes at 65 °C (McIver et al., 2020). The total volume was 25 µl, and it consisted of 12.5 µl 
of DreamTaq PCR master mix (2X) (Thermo Fisher Scientific, Waltham, USA), 7.5 µl of 
nuclease-free water (Thermo Fisher Scientific, Waltham, USA), 3 µl of genomic DNA and 1 
µl of each ERIC 1 and ERIC 2 primer (working stock concentration of 10 µM) (Versalovic et 
al., 1991). Only, 7 µl of the PCR products were loaded into a 1% (w/v) agarose (SeaKem LE 
Agarose, Lonza Bioscience, Basel, Switzerland) gel and subjected to gel electrophoresis (Bio-
Rad, Hercules, USA) at 75 V for 180 minutes using 1X Tris-acetate-EDTA (TAE) buffer 
(Thermo Fisher Scientific, Waltham, USA). A 1 kb DNA ladder (New England Biolabs, 
Ipswich, USA) was used as a molecular weight marker. Thereafter the gel was stained with 
ethidium bromide (Thermo Fisher Scientific, Waltham, USA) for 30 minutes and visualised 
using the ChemidocTM imaging system (Bio-Rad, Hercules, USA). K. pneumoniae ATCC 
BAA-1705 was used for quality control purposes. The resulting banding patterns were analysed 
using Bionumerics version 6.6.11 (Applied Maths NV, Sint-Martens-Latem, Belgium). The 
similarity of the banding patterns was assessed using the Dice coefficient. The dendrogram was 
generated using the unweighted pair group method with arithmetic averages (UPGMA), using 
1% tolerance and 0.5% optimisation. The isolates were grouped into clusters based on a 
similarity of ≥ 60%. 
 
2.2.10 Statistical analysis 
The data generated was analysed using the IBM Statistical Package for Social Sciences (SPSS) 
version 25 (IBM Corporation, New York, USA). A chi-square test of homogeneity was used 




hospitals and between the various wards. Significant differences were further examined by 
conducting multiple pairwise comparisons via the implementation of a Post-Hoc analysis using 
the Z test of two proportions with a Bonferroni correction. Chi-square test for association and 
Fischer's exact test investigated the association between the different antibiotic resistance genes 
and virulence genes. All results were considered significant when p<0.05.  
 
2.3 Results  
2.3.1 Prevalence of K. pneumoniae 
From the 777 samples collected, a total of 75 (10%) K. pneumoniae isolates were obtained over 
a period of three months. The total number of K. pneumoniae isolates recovered, was equally 
high in tertiary hospital B and district hospital D. The total occurrence of K. pneumoniae was 
lowest in central hospital A (Figure 2.1A). The total sum of K. pneumoniae isolates detected, 
was highest in the paediatric ward (Figure 2.1B). From the 11 sites included in this study, K. 
pneumoniae was only recovered from six sites, and the highest total contamination was 
observed from the occupied bed followed by the sink, mop, unoccupied bed, patient file and 
BP monitor (Figure 2.1C). Zero (0%) K. pneumoniae isolates were recovered from the nurse's 
table, door handle, drip stand, telephone and ventilator.  
Thirty (40%) of the 75 K. pneumoniae were phenotypically identified as ESBL producers. The 
proportion of ESBLs recovered from tertiary hospital B was significantly (p<0.05) higher 
compared to central hospital A and district hospital D. Although more ESBL isolates were 
detected in tertiary hospital B compared to regional hospital C, this difference was not 
significant (p≥0.05) (Figure 2.1A). The number of ESBL isolates obtained from the ICU was 





Figure 2.1: The overall proportion of non-ESBL and ESBL-producing K. pneumoniae isolates 




2.3.2 Antibiotic susceptibility testing  
The ESBLs displayed higher resistance to the antibiotics screened compared to the non-ESBLs 
(Table 2.2). A total of 29 ESBL isolates were classified as MDR. 
Table 2.2: The antibiotic susceptibility profiles for the non-ESBL and ESBL-producing K. 
pneumoniae isolates collected within the hospital environment. 
Antibiotics Non-ESBL  
N=45 
 
 ESBL  
N=30 




















Ampicillin 45 (100) 0 (0) 0 (0)  30 (100) 0 (0) 0 (0)  75 (100) 0 (0) 0 (0) 
Cefazolin 10 (22) 14 (31) 21 (47)  30 (100) 0 (0) 0 (0)  40 (53) 14 (19) 21 (28) 
Cefoxitin 1 (2) 2 (4) 42 (93)  15 (50) 0 (0) 15 (50)  16 (21) 2 (3) 57 (76) 
Ceftriaxone 1 (2) 1 (2) 43 (96)  30 (100) 0 (0) 0 (0)  31 (41) 1 (1) 43 (57) 
Meropenem 1 (2) 1 (2) 43 (96)  19 (63) 2 (7) 9 (30)  20 (27) 3 (4) 52 (69) 
Amoxicillin- 
clavulanate 
2 (4) 6 (13) 37 (82)  26 (87) 3 (10) 1 (3)  28 (37) 9 (12) 38 (51) 
Gentamicin 0 (0) 2 (4) 43 (96)  29 (97) 0 (0) 1 (3)  29 (39) 2 (3) 44 (59) 
Ciprofloxacin 0 (0) 2 (4) 43 (96)  21 (70) 9 (30) 0 (0)  21 (28) 11 (15) 43 (57) 
Tetracycline 0 (0) 0 (0) 45 (100)  10 (33) 0 (0) 20 (67)  10 (13) 0 (0) 65 (87) 
Trimethoprim-
sulfamethoxazole 
0 (0) 0 (0) 45 (100)  29 (97) 0 (0) 1 (3)  29 (39) 0 (0) 46 (61) 
Chloramphenicol 0 (0) 0 (0) 45 (100)  11 (37) 0 (0) 19 (63)  11 (15) 0 (0) 64 (85) 
Nitrofurantoin 4 (9) 10 (22) 31 (69)  18 (60) 6 (20) 6 (20)  22 (29) 16 (21) 37 (49) 
Abbreviations: R: Resistant; I: Intermediate; S: Susceptible 
 
2.3.3 Detection of virulence and antibiotic resistance genes 
The blaCTX-M group one and aac(3')-II resistance genes, were equally abundant; thus, they were 
detected in 30 (40%) isolates. The prevalence of the other resistance genes was 28 (37%) for 
blaTEM, 17 (23%) for qnrB and 14 (19%) for aac(6')-Ib. A significant (p<0.05) association 
between each of these aforementioned resistance genes, was detected. The blaSHV resistance 
gene was the most prominent; hence it was observed in 69 (92%) isolates; however, it showed 




The prevalence of the virulence genes was 71 (95%) for mrkD, 70 (93%) for wabG and 69 
(92%) for entB. All the virulence genes screened were significantly (p<0.05) associated with 
one another.  
 
2.3.4 Investigating clonality using enterobacterial repetitive intergenic consensus 
polymerase chain reaction 
The genetic diversity amongst 48 K. pneumoniae isolates was investigated using ERIC-PCR. 
At each hospital, ward and site, these selected isolates had a unique antibiogram and resistome. 
The isolates revealed 20 different ERIC-types (A to T) based on a similarity of ≥ 60%. A total 
of 13 major ERIC-types were further defined for isolates displaying similarity of ≥ 80% (Figure 
2.2). In contrast to all the other ERIC-types which were hospital-specific, ERIC-type T 
consisted of isolates from tertiary hospital B and regional hospital C (Figure 2.2). Within the 
major ERIC-types, none of the ESBL and non-ESBL isolates clustered together. Major ERIC-
type K consisted of isolates regarded as 100% identical and were recovered from the sheets of 
an occupied and an unoccupied bed in the ICU of tertiary hospital B (Figure 2.2). Major ERIC-
type M consisted of isolates from the sink and sheet of an occupied bed in the ICU of tertiary 
hospital B. These isolates shared a similarity of ≥80% (Figure 2.2). Within their respective 
clusters, isolates from ERIC-type F and ERIC-type H shared a similarity of ≥60%. ERIC-type 
F consisted of genetically similar isolates obtained from the sink and occupied bed in the 
general ward of district hospital D. ERIC-type H consisted of genetically similar isolates from 











Figure 2.2: Dendrogram depicting the ERIC-PCR profiles from 48 K. pneumoniae isolates. K. 
pneumoniae ATCC BAA 1705 was used as a positive control. The solid red line at 60% 
specifies the ERIC-type cut off whereas the dashed line at 80% specifies the major ERIC-type 
cut-off. Abbreviations: Hosp.: Hospital; A: Central Hospital; B: Tertiary Hospital; C: Regional 
Hospital; D: District Hospital; PAED: Paediatric; ICU: Intensive Care Unit; GEN: General; 
Occ. Bed: Occupied Bed; Unocc. Bed: Unoccupied Bed; P. File: Patient File; + indicates an 








































































































































































































































































































































































Cefazolin; FOX: Cefoxitin; CRO: Ceftriaxone; MEM: Meropenem; CIP: Ciprofloxacin; CN: 
Gentamicin; AMC: Amoxicillin-clavulanate; F: Nitrofurantoin; SXT: Trimethoprim-
sulfamethoxazole; TE: Tetracycline; C: Chloramphenicol.  
 
2.4 Discussion 
A study involving public hospitals situated in KwaZulu-Natal, South Africa was conducted to 
determine the prevalence, clonality, virulence and antibiotic resistance profile of K. 
pneumoniae recovered on frequently encountered surfaces in the hospital environment. The 
overall prevalence was 10%, and this low prevalence is relatively similar to the 11.5%  reported 
in Uganda (Sserwadda et al., 2018) and the 11.6% reported in Ethiopia (Getachew et al., 2018), 
involving the recovery of Klebsiella from the hospital environment. 
Tertiary hospital B had an overall higher prevalence of K. pneumoniae compared to central 
hospital A (Figure 2.1A). Although both these hospitals can receive referral patients from other 
provinces, the former hospital contains more beds; thus, it can accommodate more patients. 
The higher influx of patients may influence environmental contamination leading to a higher 
prevalence. Similarly, this can possibly explain the higher prevalence of K. pneumoniae in 
district hospital D compared to regional hospital C (Figure 2.1A), as the former hospital 
contains more beds. In addition, district hospitals support primary healthcare facilities as they 
provide services to patients referred from community healthcare centres or clinics. 
Furthermore, they also serve as a gateway for patients to access specialised care (Pillay & 
Mahomed, 2019). This dual function may also contribute to a higher inflow of patients. The 
number of people present in the hospital environment is one factor that can influence the 
quantity and types of microorganisms detected (Suleyman et al., 2018).  
Healthcare textiles such as bedsheets and staff uniforms may play a role in disseminating 
bacteria (Fijan & Turk, 2012). In this study, K. pneumoniae was recovered from the bedsheets 
of occupied and unoccupied beds (Figure 2.1C). The high prevalence on occupied beds is 
expected as bedsheets used by patients can be contaminated with bodily substances (blood, 
skin, urine and stool) containing a high number of microorganisms (Fijan & Turk, 2012). 
Carbapenem-resistant K. pneumoniae has also been detected in hospital bed linen surrounding 
the pillow in a study conducted in China (Yan et al., 2019). Healthcare workers can touch these 
surfaces during patient care, and in the absence of hand hygiene, be disseminated throughout 




problematic because a patient admitted and assigned to that unoccupied bed is at risk of 
developing an HAI caused by K. pneumoniae. The information available regarding the survival 
of microorganisms on hospital textiles after laundering differs amongst researchers due to the 
different temperatures and conditions investigated (Fijan & Turk, 2012). Furthermore, even if 
laundry processes are efficient at removing microorganisms, recontamination can occur if there 
is negligence at various post-handling processes such as sorting, ironing, folding and packing 
(Mitchell et al., 2015).  
Handwashing sinks were the second most abundant site where K. pneumoniae was recovered 
(Figure 2.1C). Moist environments such as sinks favour the survival of Gram-negative bacteria 
(Muzslay et al., 2017). Sinks also accommodate the formation of bacterial biofilms and are an 
ideal environment where bacteria can exchange resistance genes through horizontal gene 
transfer (HGT) (Grabowski et al., 2018; Kotay et al., 2017). It has been suggested that when 
hand washing occurs in a pathogen contaminated sink or sink drain, the hands of healthcare 
workers can be colonised with bacteria due to the backsplash. Contaminated hands can contact 
patients during routine care activities, thus demonstrating a possible route of transmission 
(Tofteland et al., 2013). A K. pneumoniae outbreak linked to a contaminated handwashing sink 
occurred between 2009 and 2010 in Sweden (Starlander & Melhus, 2012). This suggests that 
the effective and efficient cleaning of sinks in hospitals should be emphasised. 
Healthcare workers frequently handle patient files to write daily notes after attending to a 
patient during routine checks and after performing medical procedures (Panhotra et al., 2005). 
In this study, K. pneumoniae was also detected on patient files (Figure 2.1C). Patient files are 
vulnerable to contamination because they are often placed on multiple surfaces, such as nursing 
stations and patient beds (Chen et al., 2014). Ineffective hand hygiene between handling these 
contaminated files and touching patients increases the probability of transmission (Panhotra et 
al., 2005). Previous studies conducted in Saudi Arabia (Panhotra et al., 2005) and Taiwan  
(Chen et al., 2014), have also reported the recovery of K. pneumoniae from patient files.   
ESBL production was observed in 30 of the 75 (40%) K. pneumoniae isolates recovered, thus 
correlating with the resistance to ceftriaxone detected (Table 2.2). The ESBL percentage 
reported in this study is lower than previous studies conducted in Egypt (Afifi, 2013) and 
Ethiopia (Engda et al., 2018), where K. pneumoniae accounted for 56.25% and 42.10% of the 
ESBL isolates recovered from hospital surfaces and equipment, respectively. These differences 




of ESBL selecting β-lactam antibiotics. Secondly, the implementation of IPC measures may 
vary from optimal to suboptimal. Antibiotic-resistant bacteria emerge due to selection pressure; 
however, these microorganisms are maintained within the hospital environment due to 
inadequate IPC measures (Essack, 2006). 
Tertiary hospital B is classified as a level three healthcare facility and it had a high quantity of 
ESBLs (Figure 2.1A). The referral system suggests that medical conditions presented at 
healthcare facilities become increasingly complex and severe as the hospital classification 
levels progress, leading to the higher usage of antibiotics, especially broad-spectrum antibiotics 
(Essack et al., 2005). When third-generation cephalosporins are used, the outcome is the 
emergence of ESBLs (Pereira et al., 2004). These results are consistent with a study conducted 
on clinical isolates obtained from 16 different public hospitals situated in KwaZulu-Natal 
which found that the number of ESBL-producing bacteria was highest in tertiary hospitals 
followed by regional then district hospitals (Essack et al., 2005). Central hospital A also deals 
with complex medical cases, but it had fewer ESBLs (Figure 2.1A). Compared to other 
hospitals included in this study, central hospital A has more financial and medical resources 
that can be directed at improving IPC measures. Several factors influence the implementation 
of IPC measures. These factors include limited financial resources, inadequate infrastructure 
and poorly implemented systems. The latter consists of the unsatisfactory purchase and 
distribution of supplies such as hand disinfectant (Damani, 2007; Sastry et al., 2017).  
A significant (p<0.05) proportion of the ESBLs recovered were from ICU (Figure 2.1B). This 
finding is possibly attributable to the high intake of antibiotics in this ward as it is specifically 
designed for critically ill patients (Mora et al., 2016; Muzslay et al., 2017). Frequently 
administered antibiotics are often broad-spectrum and constant exposure can facilitate the 
emergence of MDR bacteria (Curcio, 2013). 
Majority of the ESBLs were MDR, and they exhibited higher levels of resistance compared to 
non-ESBLs (Table 2.2). A similar finding was also reported in a previous study conducted in 
Egypt (Afifi, 2013), involving isolates recovered from hospital surfaces. The resistance to 
gentamicin, ciprofloxacin and all the β-lactams screened in this study (Table 2.2), is of great 
concern as antibiotics from the aminoglycoside, fluoroquinolone and β-lactam class are often 
used to treat infections caused by bacteria within Enterobacteriaceae family such as K. 




Most isolates showing phenotypic resistance to gentamicin (Table 2.2) harboured the aac(3')-
II gene. This gene was detected simultaneously with aac(6')-Ib in some isolates but at a lower 
prevalence. Not all the isolates exhibiting phenotypic resistance to ciprofloxacin (Table 2.2) 
tested positive for qnrB. This suggests that other mechanisms were involved in this resistance. 
The high prevalence of the blaSHV gene is possibly due to the presence of the blaSHV-1 gene on 
the chromosome, resulting in the intrinsic resistance to ampicillin (Wyres & Holt, 2018).   
A great number of the ESBLs harboured the blaCTX-M resistance gene. Only variants belonging 
to group one were screened and detected. The group one primer set collectively targeted group 
one variants such as CTX-M-1, CTX-M-3 and CTX-M-15 (Dallenne et al., 2010). The latter 
is the most commonly detected in Africa (Zeynudin et al., 2018). This study found that the 
blaCTX-M gene was significantly (p<0.05) associated with the aminoglycoside and 
fluoroquinolone encoding genes screened and detected in most ESBL isolates. Co-resistance 
phenotypes to fluoroquinolones and aminoglycosides have been linked to the CTX-M type 
ESBL (Zeynudin et al., 2018). These results coincide with a study conducted in Algeria 
reporting the detection of group one variants (CTX-M-15 and CTX-M-3) in ESBL-producing 
K. pneumoniae isolates recovered from hospital surfaces. Furthermore, in most isolates the 
study also showed the association of the blaCTX-M gene with qnrB and aac(6')-Ib; however, 
most of the isolates carried the aac(6')-Ib-cr variant (Zenati et al., 2017).  
Type three pili play a significant role in biofilm formation on abiotic surfaces. In contrast, 
enterobactin is a common siderophore secreted by K. pneumoniae to acquire bound and 
unbound iron in the host environment. Iron is an essential element needed by the bacterium to 
thrive during an infection (Bellifa et al., 2013; Martin & Bachman, 2018; Paczosa & Mecsas, 
2016). These virulence factors are encoded by the mrkD and entB genes, respectively. In this 
study, the overall prevalence of the mrkD gene was 95%. This high prevalence is relatively 
similar to the 92% reported in Algeria (Bellifa et al., 2013) and the 96% reported in Brazil 
(Ferreira et al., 2019), involving the recovery of K. pneumoniae from medical devices and 
clinical isolates. However, the frequency of the entB gene observed in this study (92%), is 
slightly lower than the 100% reported in Brazil (Ferreira et al., 2019). 
There is a clustering of genetically similar isolates (ERIC-type T) between tertiary hospital B 
and regional hospital C (Figure 2.2). This is most likely possible because patients in hospital C 
can get referred to hospital B when they require services not offered by regional hospitals but 




Genetically related isolates within major ERIC-type M were isolated from the sheet of an 
occupied bed and sink in the ICU of tertiary hospital B. Similarly, related clones of ERIC-type 
F were noted from different sites (the occupied bed and sink) in the general ward of district 
hospital D (Figure 2.2). By inserting a fluorescent marker into a sink drain cover, Hota et al. 
2009 showed that during a 15-second handwash, fluorescent residues were transmitted and 
detected in the immediate vicinity as well as one metre from the sink. Researchers further 
suggested the probability of undetected microparticles travelling further than one metre (Hota 
et al., 2009). Kotay et al. (2017) demonstrated that when a sink strainer or sink bowl was 
colonised with green fluorescent protein (GFP)-expressing Escherichia coli, dispersion of the 
microorganism to surrounding surfaces occurred when the faucet was turned on (Kotay et al., 
2017). Furthermore, when water tap handles are contaminated with bacteria, there is a chance 
of hand recontamination occurring upon contact, which can nullify any handwashing that has 
happened (Bhatta et al., 2018). The recontamination of hands can result in the dissemination 
of bacteria if contact is made with other sites.  
Major ERIC-type K consisted of genetically similar isolates originating from the sheet of an 
occupied and unoccupied ICU bed in tertiary hospital B. Genetically related isolates within 
ERIC-type H were derived from a sheet of an occupied and unoccupied bed in the general ward 
of hospital A (Figure 2.2). The failure to adhere to IPC measures is a likely cause. However, 
due to the detection of K. pneumoniae on the sheets of unoccupied beds, hospital textiles 




This study is one of the very few hospital environment-based studies conducted in South 
Africa. It highlighted the prevalence of K. pneumoniae on various frequently touched hospital 
surfaces and equipment, which can be further disseminated to other sites if IPC measures are 
suboptimal. This was further supported by the recovery of genetically similar isolates from 
different surfaces within the same hospital. Some of the isolates recovered were characterised 
as ESBLs and showed high resistance to clinically significant antibiotics. Overall, the study 
emphasised the importance of regular monitoring of the hospital environment. The findings of 
this study can assist IPC staff in identifying the possible sources of transmission and assessing 
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OVERVIEW OF MAIN FINDINGS, CONCLUSION AND SIGNIFICANCE OF 
STUDY, LIMITATIONS AND FUTURE RECOMMENDATIONS 
 
3.1 Main findings 
A total of 75 (10%) Klebsiella pneumoniae isolates were successfully isolated and identified 
using phenotypic and genotypic methods. The former incorporated the usage of laboratory 
media and a series of biochemical tests. Compared to the latter, which relied on conducting 
polymerase chain reaction (PCR) targeting the khe gene (Jian-Li et al., 2017).  
The overall prevalence of K. pneumoniae differed across the selected public hospitals, with the 
highest occurrence being observed in tertiary hospital B and district hospital D. These two 
hospitals experience an increased inflow of patients leading to higher levels of environmental 
contamination. Only six sites harboured the bacterium of interest, and the highest level of 
contamination was detected on the occupied bed and sink. The former is bound to be 
contaminated as patients' beds are often covered in hospital textiles such as bedsheets or 
blankets. These textiles can be contaminated with bodily fluids which contain many 
microorganisms (Fijan & Turk, 2012). The high quantity of K. pneumoniae in sinks can be 
attributed to the moist environment favourable for Gram-negative bacteria (Muzslay et al., 
2017). The moderate contamination of unoccupied beds is a significant concern as it poses a 
threat to the next patient admitted and allocated to the contaminated bed.  
Only 30 of the 75 (40%) K. pneumoniae isolates were phenotypically characterised as 
extended-spectrum β-lactamases (ESBLs) and most were recovered from tertiary hospital B 
and the intensive care unit (ICU). The high prevalence in the areas mentioned above is probably 
due to the increased utilisation of β-lactam antibiotics, promoting the emergence of ESBLs. 
Moreover, the ESBL isolates, which mostly harboured the blaCTX-M group one gene, showed 
higher resistance levels than the non-ESBLs. The CTX-M type ESBL has been linked with co-
resistance to fluoroquinolones and aminoglycosides (Zeynudin et al., 2018). This can possibly 
explain the enhanced resistance observed in ESBL isolates and the corresponding detection of 





The different virulence genes were detected in high frequencies. These genes encode different 
virulence factors that have various functions during infections (Martin & Bachman, 2018). 
Lastly, some isolates collected from different sites (occupied bed, sink, unoccupied bed) within 
the same ward and hospital shared a genetic similarity ranging between 60-100%, suggesting 
that the dissemination of bacteria between sites occurs within the hospital environment. 
Moreover, various isolates from two different hospitals shared a genetic similarity of ≥60%, 
suggesting that bacteria can be circulated between hospitals through referral patients.  
 
3.2 Conclusions and significance of study 
The study's findings suggest that a contaminated hospital environment can play a role in 
disseminating bacteria when infection prevention and control (IPC) measures are substandard. 
This indicates that current IPC measures in the studied hospitals may not be adequate or strictly 
adhered to. The hospitals that had a high recovery of K. pneumoniae are high-risk; thus, IPC 
measures need to be emphasised to reduce bacterial transmission chances. The various surfaces 
found to be contaminated with K. pneumoniae can indicate to hospital staff which areas require 
evaluation so that current cleaning protocols in place can improve. Such action is essential 
because many South Africans rely on the overburdened public hospital for healthcare services. 
Thus, focusing on the high-risk areas can reduce contamination levels, potentially reducing the 
chances of bacterial transmission consequently preventing HAIs. Furthermore, the study 
identifies the need to regularly monitor support services linked to the hospital, such as laundry 
and linen.  
The information regarding the antibiotic resistance profiles and prevalence of ESBLs can assist 
in encouraging hospital staff to use antibiotics appropriately as some need to be preserved for 
more severe infections whereas the usage of others needs to be reduced to limit the emergence 
of specific strains. The study also highlights and emphasises the importance of IPC adherence 
as it plays a crucial role in reducing the transmission of resistant bacteria. This is vital as the 
hierarchical referral system in South African public hospitals has the potential to facilitate the 
dissemination of resistant bacteria between districts or provinces through patients. This can 
further intensify the existing problem of antibiotic resistance experienced globally. The 
detection of resistance genes can help identify and understand the different mechanisms 








There were several limitations associated with this study. The most prominent is that hospital 
staff were informed about each sampling visit beforehand; thus, this anticipated visit could 
have increased cleaning efforts and encouraged strict adherence to IPC measures, consequently 
underestimating the actual prevalence. Secondly, only hospitals from one health district were 
included in this study. Thus, the results obtained do not represent all the public hospitals 
situated in KwaZulu-Natal as the other 10 health districts were not included in the study. 
Likewise, only three wards per hospital were selected. Therefore, the prevalence of K. 
pneumoniae reported does not represent the entire hospital as other wards excluded from the 
study could be less or more contaminated with K. pneumoniae. Similarly, only 11 sites were 
included in this study. Although these surfaces were carefully selected based on literature and 
oral communication with healthcare workers, other surfaces that were not considered in this 
study could also potentially serve as reservoirs. Lastly, some of the resistance genes could not 
be sequenced to determine the exact variant involved due to cost constraints. 
 
3.4 Future recommendations 
Samples should be taken from inanimate surfaces as well as healthcare workers, janitor staff, 
patients and visitors to determine the extent of their role in disseminating bacteria. In addition, 
whole-genome sequencing (WGS) should be incorporated within these environmental studies 
as this can provide the full genetic profile of bacterial isolates in one step since some essential 
resistance and virulence genes may have been overlooked, especially those that are not readily 
associated with Klebsiella. Hypervirulent K. pneumoniae strains are slowly gaining attention 
as they acquire resistance. Therefore, future studies should focus on detecting these strains as 
they possess additional virulence factors. Phenotypic methods to investigate the biofilm-
forming ability of K. pneumoniae should be conducted. The ability to form biofilms is an 
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Appendix 1: The collection data and results for antibiotic susceptibility testing and molecular detection of resistance and virulence genes for 
each K. pneumoniae isolate included in the study. 
Isolate Collection data Antibiotics Antibiotic resistance genes Virulence genes 
Hos
p. 
















D ICU P.File R R R S S R R S R R I R + + + + + - + + + 
1SID2
* 
D ICU P.File R R R S S I R S R R I R + + + + + + + + + 
1SID3
* 
D ICU P.File R R R S S R R R R R R I + + + + + + + + + 
1SGH
1C 
D GEN Sink S S S S S S S S R S S S + - - - - - + + + 
1SGH
1D 
D GEN Sink S S S S S S S S R S S S + - - - - - + + + 
1SGH
3 
D GEN Sink S S S S S S S S R S S S + - - - - - + + + 
1SGH
4 
D GEN Sink S I S S S S S S R S I S + - - - - - + + + 
1SGJ1 
2 
D GEN Occ. 
bed 
S S S S S S S S R S S S + - - - - - + + + 
1SGJ1 
3C 
D GEN Occ. 
bed 
S S S S S S S S R S S S + - - - - - + + + 
1SGJ1 
4 
D GEN Occ. 
bed 
S I S S S S S S R S S S + - - - - - + + + 
 
Abbreviations: Hosp.: Hospital; P.File: Patient File; Occ.bed: Occupied Bed; Unocc.bed: Unoccupied bed; AMP: Ampicillin; KZ: Cefazolin; FOX: Cefoxitin; 
CRO: Ceftriaxone; MEM: Meropenem; CIP: Ciprofloxacin; CN: Gentamicin; AMC: Amoxicillin-clavulanate; F: Nitrofurantoin; SXT: Trimethoprim-





Continued Appendix 1: The collection data and results for antibiotic susceptibility testing and molecular detection of resistance and virulence 
genes for each K. pneumoniae isolate included in the study. 
Isolate Collection data Antibiotics Antibiotic resistance genes Virulence genes 
Hos
p. 
















D PEAD Mop S R S S S S S S R S I S - - - - - - - - - 
1SPF 
2 
D PAED Mop S S S S S S S S R S I S + - - - - - + + + 
1SPH
1 
D PAED Mop S S S S S S S S R S I S + - - - - - + + + 
1SPH
2 
D PAED Mop S S S S S S S S R S S S + - - - - - + + + 
1SPJ1  
1 
D PAED Occ. 
bed 
S I S S S S S S R S S S + - - - - - + + + 
1SPJ1 
1C 
D PAED Occ. 
bed 
S S S S S S S S R S S S + - - - - - + + + 
1SPJ1 
2 
D PAED Occ. 
bed 




















S I S S S S S S R S S I + - - - - - + + + 
1CGJ
1 1* 
C GEN Occ. 
bed 
R R R S S R R R R S I I + + + + + + + + + 
1CGJ
1 3* 
C GEN Occ. 
bed 
R R R S S I R S R S S R + + + + - - + + + 
1CPH
1 
C PAED Sink S I S S S S S S R S S S + - - - - - + + + 
1CPH
2 
C PAED Sink S S S S S S S S R S S S + - - - - - + + + 
1CPJ1 
1* 
C PAED Occ. 
bed 
R R R S R R R R R S R R + + + + + + + + + 
1CPJ1 
2* 
C PAED Occ. 
bed 




Continued Appendix 1: The collection data and results for antibiotic susceptibility testing and molecular detection of resistance and virulence 
genes for each K. pneumoniae isolate included in the study. 
Isolate Collection data Antibiotics Antibiotic resistance genes Virulence genes 
Hos
p. 
















C PAED Occ. 
bed 
R R R S R I R I R S R R + - + + - - + + + 
1CPJ1 
7* 
C PAED Occ. 
bed 
R R R S R R R R R S R R + + + + + + + - - 
2CPH 
1 
C PAED Sink S S S S S S S S R S S S + - - - - - + + + 
2CPH 
2 
C PAED Sink S S S S S S S S R S S S + - - - - - + + + 
2CPH 
3 
C PAED Sink S S S S S S S S R S S S + - - - - - + + + 
2CPH
4 
C PAED Sink S S S S S S S S R S S S + - - - - - + + + 
3CID
1* 
C ICU P.File R R R S S I R R R R S R + + + + + - + + + 
3CID
2* 
C ICU P.File R R R S S R R R R R I R + + + + + - + + + 
3CID
3* 










S I S S S S S S R S S I + - - - - - + + + 
1UPF
3 
B PAED Mop S I S S S S S S R S S S - - - - - - - - - 
2UIH
3 
B ICU Sink S S S S S S S S R S I S + - - - - - + + + 
2UIH
4 
B ICU Sink S R S S R I R I R S I R + - - - - - + + + 
2UIH
6 
B ICU Sink S I S S S S S S R S R S + - - - - - + + + 
2UIH
7 





Continued Appendix 1: The collection data and results for antibiotic susceptibility testing and molecular detection of resistance and virulence 
genes for each K. pneumoniae isolate included in the study. 
Isolate Collection data Antibiotics Antibiotic resistance genes Virulence genes 
Hos
p. 
















B PAED Occ. 
bed 
S I S S S S S S R S R S + - - - - - + + + 
3UIF1
* 
B ICU Mop R R R S S I R S R R R R + + + + - - + + + 
3UIF2
* 
B ICU Mop R R R S S I R S R R R R + + + + - - + + + 
3UIF3
* 
B ICU Mop R R R S S R R S R R R R + + + + - - + + + 
3UIF4
* 
B ICU Mop R R R S S R R R R R R R + - + + + - + + + 
3UID
1* 
B ICU P.File S R S S R I R I R S R S + - - - - - + + + 
3UIJ1 
1* 
B ICU Occ. 
bed 
R R R R R R R R R S R R + + + + - + + + + 
3UIJ1 
2* 
B ICU Occ. 
bed 
R R R R R R R R R S R R + + + + + + + + + 
3UIJ1 
3* 
B ICU Occ. 
bed 
R R R R R R R R R S R R + + + + + + + + + 
3UIJ1 
4* 
B ICU Occ. 
bed 




















R R R R R R R R R S S R + + + + - - + + + 
3UIH
3* 
B ICU Sink R R R R R R R R R S R R + + + + - - + + + 
3UIH
4* 
B ICU Sink R R R R R R R R R S R R + + + + - - + + + 
1MGF
1* 
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Isolate Collection data Antibiotics Antibiotic resistance genes Virulence genes 
Hos
p. 
















A GEN Mop R R R R R R R R R S I R + + + + - - + + + 
1MGF
3* 
A GEN Mop R R R S S I R S R S S R + + + + + + + + + 
1MGJ
1 1 
A GEN Occ. 
bed 
S R S S S S S S R S I I + - - - - - + + + 
1MGJ
1 2 
A GEN Occ. 
bed 
S I S S S S S S R S R S + - - - - - + + + 
1MGJ
1 4 
A GEN Occ. 
bed 










S S S S S S S S R S S S + - - - - - + + + 
1MPF
2 
A PAED Mop S R I S I S S S R S S I - - - - - - - + + 
1MPF
1 
A PAED Mop S R S S S S S S R S S S - + - - - - + + + 
1MPF
3 
A PAED Mop S R S S S S S S R S S S - - - - - - - + - 
1MPF
4 
A PAED Mop S R S S S S S S R S S S - - - - - - - - - 
1MPJ
1 1 
A PAED Occ. 
bed 
S R I S S S S S R S S I + - - - - - + + + 
1MPJ
1 2 
A PAED Occ. 
bed 
S I S S S S S S R S S S + + + + - - + + + 
2MPC
1 
A PAED BP 
monit
or 
S I S S S S S S R S I S + - - - - - + + + 
2MPC
2 
A PAED BP 
monit
or 
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Appendix 9: Agarose gel electrophoresis images showing the molecular amplification of the 


















A: mrkD (226 bp) and wabG (683 bp) amplified from K. pneumoniae; B: entB (385 bp) 
amplified from K. pneumoniae; C: blaTEM (800 bp) amplified from K. pneumoniae; D: blaCTX-
M group one (688 bp) and aac(3')-II (877 bp) amplified from K. pneumoniae; E: blaSHV (713 
bp) amplified from K. pneumoniae; F: qnrB (264 bp) and aac(6')-Ib (472 bp) amplified from 
K. pneumoniae. PCR products were run alongside a 100 bp molecular weight marker.  
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